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The interaction of GnRH with its receptor represents a crucial point for control of
reproduction. Additionally, the porcine GnRH receptor (GnRHR) gene is a positional
candidate for genes influencing reproductive efficiency, residing in a similar
chromosomal region as a QTL for ovulation rate (OR). Gonadotropic gene expression in
lines of swine divergent for OR may provide insight into the phenomena of increased
litter size. Chinese Meishan (OR=14.5), a white crossbred line selected based on an
index of OR and embryonic survival (OR=17.8), and a Control line (OR=13.2) were
evaluated. Following three (Index and Control) or six (Meishan) estrous cycles, gilts
were ovariectomized and treated with a GnRH antagonist (SB-75) or 0.9% saline at 60,
36 and 12 hours prior to sacrifice. Blood samples were collected prior to treatment and at
sacrifice. Serum LH and FSH levels were determined by RIA and RNA was extracted
from anterior pituitary tissue. In all lines, LH was reduced to basal levels by SB-75
treatment; however, FSH was reduced in the Control line only. Levels of GnRHR and
gonadotropin subunit gene expression were measured by quantitative real-time PCR.
Expression of the GnRHR gene prior to treatment was highest in Meishan, intermediate
in Index and lowest in Control. Levels of GnRHR gene expression were reduced after
treatment in Control and Index, but not Meishan gilts. Initial amounts of glycoprotein αsubunit mRNA were highest in Control and Index compared to Meishan. Further, values

decreased following treatment in pituitaries from Control and Index lines only. Prior to
SB-75 treatment, FSHβ-subunit mRNA levels were higher in Control and Index
compared to Meishan, decreasing in Control and Index, but not Meishan after treatment.
Expression of the LHβ-subunit gene was highest in Control, intermediate in Index and
lowest in Meishan; however amounts of mRNA decreased in Control and Index
following treatment and remained unchanged in Meishan.

Affymetrix GeneChip®

Porcine Genome Arrays were run on pooled RNA from each breed x treatment group in
duplicate and gene expression analyzed. Treatment with the GnRH antagonist, SB-75,
decreased or increased expression of 30, 17 and 33 genes in Control, Index and Meishan
gilts, respectively, of which 14, 7 and 11 genes were expressed at greater than 2-fold over
gilts treated with vehicle. Twenty-three genes were down-regulated in Control gilts and 7
genes had increased expression levels compared to vehicle treated females. Expression
of 12 genes was decreased in the anterior pituitary glands of Index line gilts, whereas
only 5 genes were up-regulated following treatment with SB-75. Gene expression in
ovariectomized Meishan gilts was increased in 25 and decreased in 8 genes. Thus, gene
expression patterns in response to treatment with a GnRH antagonist suggest differential
mechanisms underlying gonadotrope function between lines of swine.
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CHAPTER I

INTRODUCTION

Prolificacy is a fundamental measure of productivity in the swine industry. Even
a modest increase in litter size can have a considerable effect on the overall profitability
of swine production. For instance, an increase in litter size of 0.2 pigs per litter on a
10,000 sow operation could net a producer nearly $99,000 in additional profit dependent
on market prices (Levis, 2000). However, average litter size in the U.S. has been nearly
static over the past 28 years, gaining approximately 1.7 pigs per litter overall (7.17 and
8.85 pigs per litter in 1975 and 2003, respectively) or 0.057 pigs per litter per year
(USDA, 1976; USDA, 2004). Thus, there is still room for improvement in litter size.
Two primary determinants of litter size are ovulation rate and uterine capacity.
While uterine capacity is a key component, it is not easily quantified, making selection
for this trait difficult.
ovulation rate.

Uterine capacity aside, potential litter size is determined by

In addition, ovulation rate can be improved in a number of ways,

including nutritional flushing and hormonal treatment. However, little is known about
the mechanisms controlling increased ovulation rate.
Ovulation rate is influenced by levels of several hormones including the
gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH).
Gonadotropin-releasing hormone (GnRH) from the hypothalamus binds to its receptor
(GnRHR) on gonadotrope cells of the anterior pituitary gland, stimulating the synthesis
and secretion of both FSH and LH (Fig. 1.1). The gonadotropins then act on the ovaries,
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Figure 1.1. Diagram of the Hypothalamic-Pituitary-Gonadal Axis
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FSH stimulating follicle recruitment and LH inducing ovulation. Steroid hormones, such
as estrogen and progesterone, are released from the ovaries and feedback at the level of
the hypothalamus and anterior pituitary gland to regulate subsequent GnRH and
gonadotropin production. Therefore, reproductive function is highly dependent on the
interaction between GnRH and its receptor, as well as expression of the subunit genes
encoding the gonadotropins.
The genomic sequence for the porcine GnRHR gene was reported by Z. Jiang and
associates (2001). The gene for the GnRHR lies in a similar chromosomal region as a
quantitative trait locus (QTL) for ovulation rate (Rohrer et al., 1999). Therefore, the
GnRHR gene represents both a physiological and positional candidate for genes
determining ovulation rate in swine.

Further, sequence analysis reveals several

polymorphisms within the coding sequence for the GnRHR gene between Chinese
Meishan and white crossbred pigs, resulting in at least three amino acid substitutions.
Meishan females produce four to five more piglets per litter than occidental white
crossbred lines due, in part, to increased ovulation rate (White et al., 1993; Christenson et
al., 1993). Consistent with this model, Dr. Rodger Johnson has developed a line of pigs
at the University of Nebraska – Lincoln (UNL) that were selected for greater than 14
generations based on an index of ovulation rate and embryonic survival at 50 d gestation.
This line of white crossbred pigs (Index) ovulates seven more eggs each cycle
(Generation 10; Johnson et al., 1999) and produces 2.53 more live born piglets per litter
than control animals (Control; Generation 19; Petry and Johnson, 2004).
If differences in GnRHR and gonadotropin subunit gene expression between
Meishan, Index and Control lines are determined, this could lead to a better
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understanding of the mechanisms that determine ovulation rate. Using these mechanistic
differences, a DNA test could be developed to screen animals for the capacity to produce
large litters. Ultimately, specific genetic information from animals with an increased
ovulation rate could be used to produce transgenic pigs.

This would allow the

opportunity to increase ovulation rate in swine, while maintaining the beneficial traits
characteristic of a certain breed or line. These animals would be very valuable to pork
production worldwide.
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CHAPTER II

Review of Literature

Role of GnRH and its Receptor on Reproductive Function
Ovulation rate may be influenced by circulating levels of FSH and LH. The
production of these hormones, also known as gonadotropins, is controlled by the
reproductive axis, comprised of the hypothalamus, anterior pituitary gland and gonads
(Fig. 1.1). The decapeptide, gonadotropin-releasing hormone (GnRH), is released in a
pulsatile fashion from the hypothalamus into the hypothalamo-hypophyseal portal system
and travels to the anterior pituitary gland. At the anterior pituitary gland, GnRH binds to
its seven-transmembrane, G-protein-coupled receptor on the plasma membrane of
gonadotrope cells. Upon binding to its receptor, GnRH, through intracellular signaling
cascades including the adenylate cyclase/cAMP and phospholipase C/inositol
triphosphate (IP3)/diacylglycerol (DAG)/protein kinase C (PKC) pathways, stimulates the
expression of several genes including the common α-glycoprotein subunit, FSHβ- and
LHβ-subunits, and the GnRHR itself. The expression of the common α-subunit, in
combination with the specific LHβ- and FSHβ-subunit genes, is responsible for the
synthesis of the gonadotropins within the gonadotrope cells and subsequent secretion of
the gonadotropins into the bloodstream (Fig. 2.1). The gonadotropins then act on the
ovaries of the female to recruit follicles (FSH) or induce ovulation (LH). Steroids
produced by the ovaries, such as estradiol-17β (granulosa cells) and progesterone (luteal
cells), provide feedback at the level of both the hypothalamus and anterior pituitary gland
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Figure 2.1. Diagram of a gonadotrope cell
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to regulate subsequent production and release of GnRH and the gonadotropins,
respectively.

Porcine Estrous Cycle
The porcine estrous cycle averages 21 days, but ranges from 17 to 25 days. The
estrous cycle can be categorized into four periods: 1) proestrus, a time of increasing
follicular growth and estradiol-17β production, 2) estrus, a period of sexual receptivity
and ovulation, 3) metestrus, when formation of corpora lutea occurs and progesterone
production begins, and 4) diestrus, a time of maximal progesterone production from fully
functional corpora lutea. During the estrous cycle, levels of hormones fluctuate to
promote the selection and development of follicles to be ovulated. Following ovulation,
ruptured follicular tissue forms corpora lutea. The corpora lutea produce progesterone
which acts negatively on LH secretion by the hypothalamus and anterior pituitary.
As the estrous cycle progresses, levels of progesterone decline (Day 12 to 14) and
follicles begin to develop. Around the same time, oxytocin promotes prostaglandin F2α
production in the uterine endometrium, which is released and transported to the ovaries
via the uterine vein and ovarian artery causing regression of the corpora lutea.

If

fertilization of the oocytes and embryonic development occur, the presence of estradiol17β shunts prostaglandin F2α into the uterine lumen where it is metabolized, thus
maintaining the corpora lutea. In cyclic females, as the corpora lutea regress, levels of
LH begin to rise, signaling the beginning of the follicular phase (proestrus). Increasing
levels of estradiol-17β, produced by the developing follicles, primes the gonadotrope
cells and signals the preovulatory LH surge. The preovulatory surge of LH signals the
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ovary, and the oocytes are ovulated shortly thereafter. A diagram of the porcine estrous
cycle is presented in Fig. 2.2.

Determination of Ovulation Rate
Role of Gonadotropins and Their Receptors. Sensitivity to GnRH and other
hormones or number of GnRHRs present on the anterior pituitary gland may stimulate
higher levels of gonadotropin production and thus increase ovulation rate. The response
of gonadotrope cells to GnRH to produce gonadotropins is correlated with the number of
GnRHRs present on the cell surface (Wise et al., 1984). There is evidence that elevated
amounts of gonadotropins may contribute to increased ovulation rate. A study by Knox
et al. (2003) indicated that concentrations of both FSH and LH were elevated in lines of
swine with increased ovulation rates (17 to 26 CL) when compared to control lines (12 to
16 CL). Levels of FSH could aid in determination of ovulation rate via: 1) enhanced
recruitment of follicles during development, 2) decreased follicular atresia during the
luteal phase, or 3) increased selection during the beginning of the follicular phase. Van
de Wiel et al. (1981) reported an FSH surge coinciding with the preovulatory LH surge in
pigs, which was later substantiated (Diekman and Trout, 1984). Immediately following
ovulation, FSH levels rose and attained a maximum level at Day 3 after the LH surge.
Levels of FSH then decreased until Day 7 following the LH surge and remained at an
intermediary level for the remainder of the estrous cycle. The FSH surge following
ovulation has been shown to cause an increase in small follicle (<4 mm) populations in
pigs (Guthrie et al., 1995) indicating FSH may be involved in early follicular recruitment
at the beginning of the estrous cycle. In contrast, higher ovulation rates may be a result
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Figure 2.2. Changes in reproductive hormones during the estrous cycle in the pig.
From Knox et al. (2003).

11
of prolonged exposure to FSH during follicular recruitment. Exposure to increased
concentrations of FSH during the estrous cycle may improve both the viability and
number of recruited follicles.
The number of follicles recruited might depend on FSH concentrations, other
regulatory factors, or the number of FSH responsive follicles at recruitment, although it is
not known how the latter might work (Cardenas et al., 2002). The importance of FSH in
follicular recruitment is indicated by FSH induced increases in ovulation rate.
Exogenous means of increasing FSH, such as active immunization against inhibin,
increase both FSH concentration and ovulation rate in gilts (King et al., 1993).
Treatment with FSH on Day 15 and 16 of the estrous cycle improved ovulation rate,
whereas no increase was observed when treatment was given after Day 16 (Hunter,
1979). These days of treatment correlate with follicular recruitment in the pig. While no
large intrinsic increase in FSH level is observed in pigs coinciding with follicular
recruitment (Flowers et al., 1989), there is a small increase in FSH near estrus, with a
second increase approximately 72 h later. There is also a gradual decline in FSH from
the time of luteolysis to estrus with a noted decline in FSH receptors (Brinkley, 1981).
Follicle stimulating hormone appears to be important in follicular recruitment and may be
important in later stages of development to block new recruitment after a certain
timepoint.
Levels of plasma FSH during prepubertal development were higher in a line of
gilts selected for an increased number of CL (Ford et al., 2001). In these gilts, plasma
FSH levels at 85 days of age correlated with subsequent ovulation rate. In another study
using gilts from a separate selection pool, it was suggested there was a correlation
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between FSH at 58 and 90 days and subsequent ovulation rate, but not 124 days
suggesting the optimal age when the correlation occurs may vary (Cassady et al., 2000).
Ford and associates also reported that FSH concentrations of 34 day old gilts were good
indicators of differences in FSH production between lines, with gilts selected for
increased ovulation rate possessing a greater intrinsic capacity for FSH synthesis than
control females. However, by 150 days of age, FSH levels did not differ between lines,
suggesting that negative feedback mechanisms had matured and the potential for FSH
synthesis was no longer the limiting factor in FSH secretion (Cassady et al., 2000).
Follicular development is dependent on the action of FSH and LH; however, the
ability of the gonadotropins to act on follicles is dependent on expression of the
gonadotropin receptors in ovarian tissue (Lucy et al., 2001). Primary follicles (one layer
of cuboidal granulosa cells) may have an initial dependence on FSH as implied by
expression of the FSH receptor, but not LH receptor, gene in granulosa cells (Yuan et al.,
1996). As follicles continue to develop, there is a change from FSH to LH dependence at
the 2 to 4 mm stage (Lucy et al., 2001). The level of LH receptor gene expression
increases in granulosa and theca interna cells while the amount of FSH receptor mRNA
decreases as follicular development continues (Yuan et al., 1996). Further, FSH receptor
mRNA is reduced in 4 mm follicles and absent in follicles greater than 4 mm. Smaller
follicles continue to express FSH receptor mRNA; however, larger follicles suppress FSH
to basal levels (Lucy et al., 2001). The loss of circulating FSH may be a mechanism to
control the growth of new follicles whereas large antral follicles continue to grow and
ovulate. Levels of FSH during the preovulatory period may also play a role in the
selection of follicles from the pool for the next period of development (Yuan et al.,
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1996).

Follicular Recruitment. In the pig, follicular recruitment occurs between Day
14 and 16 of the estrous cycle (Clark et al., 1982). By Day 16, there are approximately
40 to 60 follicles 2-6 mm in diameter between both ovaries. Approximately 30 to 40
percent will be selected to ovulate and the remainder will undergo atresia (Grant et al.,
1989).

Small changes in recruitment number or atretic follicles are capable of

influencing the eventual number of ovulations. Thus, ovulation rate is regulated within a
relatively narrow range. Therefore, selection and maintenance of a large follicle pool is
critical to increased ovulation rate.

GnRH Receptor and Quantitative Trait Loci for Ovulation Rate. Several
QTL have been suggested for ovulation rate in the pig. A QTL is a marker at a particular
location, or region, on a chromosome containing a gene that is associated with a
quantitative trait that is being measured. There is evidence for an ovulation rate QTL on
porcine chromosome 8 (Wilkie et al., 1996; Rohrer, 1999; King et al., 2003), 9 (Cassady
et al., 2001) and 15 (Rathje et al., 1997; Rohrer et al., 1999; Wilkie et al., 1999). There is
also evidence for QTL corresponding to other traits that would affect litter size including
number of fully formed pigs on chromosome 11, number stillborn on chromosomes 5 and
13 (Cassady et al., 2001), and uterine capacity on chromosome 8 (Rohrer et al., 1999).
While these QTL are of interest in relation to litter size, the porcine GnRHR gene is
located in a similar region of chromosome 8 as a QTL for ovulation rate detected in a
Chinese Meishan-White Composite population (Rohrer, 1999). Therefore, the GnRHR
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gene represents a positional candidate for genes influencing ovulation rate in swine.
Interestingly, the QTL for ovulation rate on chromosome 8 was initially identified in the
Control and Index lines (Rathje et al., 1997), however, a study in the same lines using a
greater number of animals failed to confirm the QTL (Cassady et al., 2001).
The cDNA sequence for the porcine GnRHR gene has been known for some time
(Weesner and Matteri, 1994); however, the genomic DNA sequence for the porcine
GnRHR gene was only recently reported by Z. Jiang and co-workers (2001).

The

identification of the genomic DNA sequence has allowed sequence analysis to be
performed on the regulatory region (promoter) of the porcine GnRHR gene. Several
sequence differences have already been reported within the GnRHR gene promoter
between Chinese Meishan and white crossbred pigs (Z. Jiang et al., 2001).

These

differences may change how the gene is regulated and expressed.

Potential Genes Affecting Ovulation Rate. Several genes of interest in regard
to determination of ovulation rate have been identified in sheep and comparatively
mapped to other species. The Fecundity Booroola (FecB) gene is a mutation at a single
locus in the Booroola Merino breed of sheep. The mutation is additive for ovulation rate,
resulting in an increase of 1.65 ovulations per copy of the gene (Piper et al., 1985).
While the number of follicles and subsequent ovulations increase in animals with this
gene, there is a reduction in follicle size. Follicles in FecB animals mature at a smaller
size and are more responsive to FSH early in development. The FecB gene has been
mapped to ovine chromosome 6 (Montgomery et al., 1993; Montgomery et al., 1994).
This is of interest as much of ovine chromosome 6 maps to porcine chromosome 8, on
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which a QTL for ovulation rate has been mapped (Rohrer, 1999). In point of fact, the
porcine homologue of the ovine FecB gene, BMPR1B, has been mapped to the q arm of
porcine chromosome 8 (King et al., 2003).
The Inverdale (FecX) locus was identified in a family of Romney sheep. The
gene was discovered in a flock screened for increased litter size. This gene acts in
heterozygous carrier females to increase ovulation rate by one oocyte (Davis et al., 1991;
Davis et al., 1995). In contrast, homozygous females are infertile. There is further
evidence of multiple loci in different populations of sheep, including the Cambridge,
Belclare and other breeds, which act in a similar manner as the FecB and FecX genes
(Montgomery et al., 2001).
Prolactin may also have a role in determining ovulation rate.

Prolactin is

involved in differentiation of mammary gland cells and signaling those cells to produce
milk proteins. Recently, it was discovered that the porcine prolactin receptor, found on
chromosome 16 (Vincent et al., 1997), is polymorphic at its locus, having two possible
alleles. This polymorphism has become an area of interest as a possible marker for litter
size or ovulation rate. Based on this, van Rens et al. (2003) examined the effect this
polymorphic site had on several traits, including ovulation rate. This group found a
significant effect on number of corpora lutea between the different polymorphisms,
which equated to an increase in ovulation rate. They noted that the polymorphism is
within the last exon of the prolactin receptor gene. This may cause a difference in protein
structure, which may in turn lead to differences in receptor mediated signal transduction
after binding of prolactin, thereby changing its action. The increase in ovulation rate was
attributed to an increase in the antral follicle pool, which could cause an increased
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ovulation rate during the proceeding cycle. While they were unable to determine whether
the prolactin receptor was a causative gene or marker, it was indicated that it is more
likely a candidate for ovulation rate than litter size.
In gilts, the prolactin receptor seems to have a role in increasing ovulation rate
with emphasis on the A allele. In contrast, prolactin receptor knockout mice did not
exhibit any difference in ovulation rate when compared to wild type (Grosdemouge et al.,
2003). When these mice were superovulated, there was no effect on ovulation rate
suggesting that prolactin had no effect on ovarian responses to gonadotropins. Thus, it
was determined that prolactin receptor was important for corpora lutea maintenance, but
had no role in folliculogenesis, ovulation rate or corpora lutea formation in mice.
One locus of the estrogen receptor gene has been associated with increased
ovulation rate (Rothschild et al., 1996). Using gilts of purebred Meishan and Meishan x
Large White crossbred animals it was determined that the estrogen receptor B allele
caused an additive effect for total number born and number born alive. The greatest
effect of the B allele was associated with the Meishan breed, with three pigs per litter
over the other lines. Meishan crossed with Large White had a first parity additive effect
of 1.2 pigs per litter per copy of the B allele, and 0.9 pigs per litter per copy over all
parities. Large White (Yorkshire background) alone had a first parity additive effect of
0.6 pigs per litter per copy of the B allele, and 0.5 pigs per litter per copy over all parities.
Rothschild and associates also reported that the frequency of the estrogen receptor B
allele increases as selection is focused on increasing litter size.
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Index, Meishan and Control Lines of Swine
Reproductive Traits. Females of the Meishan, Index and Control lines of swine
differ in litter size. Traits contributing to this difference include follicular development,
ovulation rate, embryonic survival, uterine capacity and prenatal survival throughout
gestation (Christenson et al., 1993). While uterine capacity is a primary determinant, it is
not easily quantified or feasible for selection purposes. Ovulation rate however, can be
manipulated through nutrition or hormonal treatment.
Meishan females produce four to five more piglets per litter than occidental white
crossbred lines due, in part, to increased ovulation rate (White et al., 1993; Christenson et
al., 1993).

Thus, Meishan females may harbor genetic differences and alternative

mechanisms with the potential to enhance the reproductive performance of white
crossbred pigs (Haley et al., 1993). Consistent with this model, Dr. Rodger Johnson
developed a line of pigs at the University of Nebraska – Lincoln (UNL) that were
selected for greater than 14 generations based on an index of ovulation rate and
embryonic survival at 50 d gestation. This line of white crossbred pigs (Index) ovulates
seven more eggs each cycle (Generation 10; Johnson et al., 1999) and produces 2.53
more live born piglets per litter than control animals (Control; Generation 19; Petry and
Johnson, 2004).

Endocrine Characteristics. One hypothesis for variances observed in ovulation
rate is different endocrine levels throughout the estrous cycle among lines of swine.
Another possible explanation is differences in disparity of hormone exposure, such as
FSH, between the lines. Concentrations of FSH, LH, estradiol-17β and progesterone did
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not differ between Index and Control line sows during the estrous cycle (Mariscal et al.,
1998). Similarly, peak gonadotropin concentrations and the area under the curve for FSH
and LH did not differ between Large White and Meishan sows prior to the LH surge
(Hunter et al., 1996). In contrast, Knox et al. (2003) reported FSH and LH levels were
increased during the ovulatory phase in the Index line. Also, FSH was elevated during
the luteal phase and was associated with an increased ovulation rate in Index compared to
Control line gilts.
When recently ovariectomized gilts were challenged with estradiol-17β, response
of LH secretion was greater in a hybrid white line of pigs compared to Meishan (Tilton et
al., 1994). Levels of LH were higher in Meishan gilts compared to white line pigs prior
to ovariectomy. Mean plasma LH was comparable between the lines up to 60 h after
treatment with estradiol-17β, but were again greater in Meishan gilts after 60 h. Levels
of FSH were higher prior to and following estradiol-17β treatment in Meishan gilts but
followed a similar pattern of secretion to that of the hybrid white line. Gilts from the
previous estradiol-17β study were subjected to an intramuscular bolus injection of GnRH
approximately 14 days following ovariectomy. Plasma levels of LH were greater in the
hybrid white line compared to Meishan gilts. Levels of FSH were higher in the hybrid
white line prior to, and following GnRH administration, with the pattern of secretion
differing following GnRH challenge. When treated with porcine follicular fluid devoid
of steroid hormones, FSH levels declined 35 and 20% in hybrid white line and Meishan
gilts, respectively, with no effect on LH levels (Tilton et al., 1994).

Levels of inhibin

were significantly higher during the preovulatory period in Meishan gilts but were not
accompanied by a reduction in FSH levels (Hasagawa et al., 1988). Hunter and others

19
(1996) reported that inhibin was increased before and after the LH surge in Meishan
compared to Large White females, and was directly correlated to ovulation rate. These
data suggest that Meishan females may be less sensitive to inhibitory feedback by the
ovary and differential regulation of gonadotropin secretion may be an important
contributor to the higher prolificacy observed in Meishan females.
Following GnRH challenge, Meishan sows had a smaller LH surge and lower
plasma LH levels than Large White contemporaries (Wise et al., 2001) which is in
agreement with previous studies in gilts by Tilton and associates (1994). Following
ovariectomy, LH levels increased more rapidly and peaked at a higher level in Large
White than Meishan sows. When the ovariectomized sows were treated with SB-75,
Meishan sows exhibited a more swift recovery of LH levels than their Large White
contemporaries. A long decline in FSH levels was observed in Meishan sows following
SB-75 treatment whereas little change was seen in Large White females, suggesting a
slower clearance rate of FSH in Meishan sows.

Follicular dynamics. Follicular comparisons were made between Meishan and
Large White hybrid gilts following their fifth estrous cycle. Biggs et al. (1993) reported
that Meishan gilts had smaller follicles that contained less follicular fluid, but had similar
amounts of DNA in the granulosa cell layer and a higher concentration of estradiol-17β
within the follicle compared to Large White hybrids.

The higher concentration of

estradiol-17β indicates that the Meishan follicles were more advanced in development
than their time-wise contemporary follicles in the Large White hybrids. This difference
may be explained by the amount of aromatase activity in granulosa cells, which is greater
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in Meishan gilts (Hunter et al., 1993), as the capacity would exist for more androgens to
be converted into estrogens. The increased concentration of estradiol-17β within the
follicle may provide a more optimal environment for oocyte maturation.
Disparity among the developing follicles can also impact ovulation rate. This is
evident when a comparison is made between Chinese Meishan and Large White females.
Meishan sows have a greater ovulation rate than their Large White contemporaries (27.7
compared to 17.6 corpora lutea; Miller et al, 1998). Meishan females also have a greater
number of follicles that are 2 mm or larger on Day 16 of the estrous cycle than Large
White females.

However, in Large White sows the number of follicles decreases

between Day 16 and 19, whereas the number of follicles remains unchanged in Meishan
sows (Miller et al., 1998).
The same is true for animals of the UNL Index line (Yen et al., 2005). Gilts of
the Index and Control lines begin the follicular phase of the estrous cycle with
recruitment of a similar number of follicles ≥ 2 mm. During progression of the follicular
phase, gilts of the Index line are able to maintain a larger selection pool containing more
estrogen-active follicles than Controls (Yen et al., 2005). It is also possible that follicles
ovulated in Index females are smaller than those of Control females (Kelly et al., 1988).

Oocyte Development. Pope et al. (1990) postulated that less advanced oocytes
became less advanced embryos and succumbed to early mortality. Pope and associates
also noted that in Large White gilts, 70% of oocytes were ovulated in a short amount of
time, while the remaining 30% were ovulated over a more prolonged period of time, with
oocytes ovulated first becoming more developed and viable.

Upon comparison of
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follicles in Meishan and Large White hybrid gilts within 8 h of ovulation, it was found
that oocytes of Meishan gilts were at more advanced stages (Hunter et al., 1993). Thus,
increased litter size in the Meishan breed may be attributed to more mature oocytes being
ovulated, fertilized and yielding more advanced embryos, increasing the odds of survival.
Overall, Meishan females appear to have a shorter luteal and longer follicular phase than
White crossbreds (Hunter et al., 1996). This may cause recruitment to occur over a
longer period of time allowing a larger number of oocytes to undergo final maturation
and ovulation.

GnRH and GnRH Receptor
Structure. Binding of the decapeptide, GnRH (pGlu-His-Trp-Ser-Tyr-Gly-LeuArg-Pro-Gly-NH2), to its cognate receptor on the plasma membrane of gonadotropes
within the anterior pituitary gland is a fundamental regulator of reproductive function.
Released in a pulsatile manner from the hypothalamus, GnRH binding to its receptor
stimulates release of the gonadotropins, FSH and LH. Each pulse of GnRH stimulates a
complimentary LH pulse, but FSH pulses are less distinctive (Millar et al., 2004).
Gonadotropin-releasing hormone receptors have an amino terminus, followed by seven
transmembrane α-helix domains connected by three extracellular domains and three
intracellular loops, typical of G-protein-coupled receptors (GPCRs; Fig. 2.3).
Conservation of the 10 amino acids and amino and carboxyl termini among GnRH
species indicates the importance of these features in binding. However, variability in
position 8 of functional GnRH analogues suggests that most residues are acceptable for
this position. Nevertheless, for high-affinity binding to take place at the mammalian
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Figure 2.3. Structural representation of the human GnRHR. Adapted from Neill (2002).
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GnRHR, arginine must be in position 8 (Sealfon et al., 1997). Thus, it appears that
selectivity of different GnRHRs is dependent on the amino acid residue that occupies
position 8 in GnRH ligands.

Internalization and Recycling. Following synthesis, GPCRs are packaged in the
Golgi apparatus and transported to the cell membrane. Once at the membrane, GPCRs
may undergo endocytosis into endosomes whether an agonist is present or not, however
agonist induced endocytosis is much more rapid (Koenig and Edwardson, 1997). Once
within the endosome, GPCRs can either be recycled back to the membrane or targeted to
lysosomes for degradation (Fig 2.4). It appears that this determination is made in the
early endosome, with the default pathway being recycling (Koeing and Edwardson,
1997). Dissociation of the ligand from receptor is accomplished by increasing acidity
within the endosome. Thus, receptors on the membrane are derived from both de novo
synthesis and recycling of internalized receptors (Koeing and Edwardson, 1994).

Role of C-terminal Tail. G-protein-coupled receptor activation involves
phosphorylation of the receptor and is typically followed by internalization and
desensitization. However, loss of the receptor due to internalization does not appear to be
required for the gonadotrope to become desensitized to GnRH or an antagonist (Gorospe
and Conn, 1987). Phosphorylation by agonist binding is usually more rapid (McArdle et
al., 2002). G-protein-coupled receptors are internalized by endocytosis via clatherincoated vesicles whose formation is controlled by a dynamin collar that pinches off the
vesicle from the membrane following ligand binding (Schmid, 1998). Once receptors
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ligand

Figure 2.4. Diagram of receptor cycling. Once internalized, the ligand dissociates from
the receptor, which is either recycled or targeted to lysosomes for
degradation. Adapted from Koenig and Edwardson (1997).
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have been internalized they are either recycled to the cell membrane, or marked for
degradation by lysosomes.

Unique to the mammalian GnRHR is the absence of a

carboxy-terminal tail normally present in all G-protein-coupled receptors, including
GnRH Type II receptors (GnRH II-R) and non-mammalian GnRHR. Stimulation of Gprotein-coupled receptors causes phosphorylation of intracellular amino acids, some of
which are situated within the C-terminal tail. The lack of a C-terminal tail in the
mammalian GnRHR may explain its inability for rapid desensitization, as key
phosphorylation sites may be absent (Heding et al., 1998).
Several studies have demonstrated the importance of the cytoplasmic C-terminal
tail in internalization and desensitization.

By attaching the C-terminal tail of rat

thyrotropin-releasing hormone receptor to the rat GnRHR, Heding and associates (1998)
demonstrated an increase in internalization rate and desensitization of the mutant GnRHR
compared to wild type rat GnRHR. Adding the C-terminal tail of the catfish GnRHR to
the rat GnRHR caused agonist-induced phosphorylation and rapid desensitization
(Willars et al., 1998). β-arrestin is important in desensitization, internalization and downregulation of the receptor (McArdle et al., 2002). Phosphorylation of amino acids in the
C-terminal tail appears to be important to facilitate β-arrestin binding. It would appear
that the absence of the C-terminal tail in GnRHR causes their resistance to desensitization
(Davidson et al., 1994). Dynamin has been implicated in fission of clatherin-coated
vesicles prior to internalization (Takei et al., 1995). To explore the dynamin dependence
of GnRHR internalization, Heding et al. (2000) co-transfected COS cells with GnRHR
and a GTPase-deficient mutant of dynamin. In this study, the mutant dynamin inhibited
internalization of GnRHR more in catfish GnRHR than rat. Thus, based on the previous
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data, it would appear that the C-terminus is important not only in β-arrestin translocation,
but may also target the receptor for dynamin-dependent internalization (Miller and
Lefkowitz, 2001).

Processing. Once internalized the GnRH ligand and GnRHR are processed
separately (Cornea et al., 1999). To demonstrate this, GH3 cells were transfected with
GnRHR and treated with a GnRH antagonist. Internal cell concentration of the GnRH
agonist increased for 2 h, whereas the concentration of GnRHR peaked 80 minutes
following activation. Cornea and associates (1999) also noticed that there were still free
GnRHR on the cell membrane even after the agonist had been internalized. It was
suggested that following internalization GnRH is freed from GnRHRs and receptors can
be transported back to the cell membrane.
In addition, estradiol has a role in priming GnRHR numbers on the membrane of
gonadotrope cells. Treatment of ovine pituitary cells with estradiol caused an increase in
the number of GnRHRs on the cell membrane by approximately 100%, but rate of
internalization was not changed (Hashizume et al., 2001). It does not appear that the
percentage of GnRHRs that are internalized depends on the number of GnRHR within the
membrane, or that a decrease in receptor internalization is the cause of enhanced pituitary
sensitivity to GnRH by estradiol.

Levels of GnRH Receptor in Gonadotropes
Determination of the number of GnRHR present on the plasma membrane of
gonadotrope cells within the anterior pituitary gland is a dynamic process and depends on
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the physiological state of the individual. In the rat anterior pituitary gland, there were
alterations in the number of GnRHRs, but not affinity, during cyclicity, lactation and
aging (Marian et al., 1981). The absence of a change in binding affinity, but fluctuation
in numbers of GnRHR, during the estrous cycle has also been observed in mice (Naik et
al., 1984) and hamsters (Adams et al., 1981). Marian and associates (1981) also reported
that the number of GnRHR among age groups was highest in weanling pups, although
they had low levels of gonadotropin secretion. Levels of GnRHR in pregnant beef
heifers were approximately 74% the level of those of estrus, whereas anestrous heifers
had the lowest number of GnRHR at a level that was 45% that of concentrations detected
during estrus (Schoenemann et al., 1985).
During the rat estrous cycle, GnRHR levels were lowest in the late afternoon and
evening of estrus through metestrus. The numbers of GnRHR doubled by the evening of
diestrus, remained elevated through the afternoon of proestrus, and declined coinciding
with the preovulatory LH surge (Clayton et al., 1980). Funabashi and associates (1994)
also reported that the number of GnRHRs increased during diestrus (Day 3) and remained
elevated through the afternoon of proestrus (Day 4) of the rat estrous cycle. The amount
of GnRHRs was greatest immediately prior to the preovulatory LH surge in the ewe
(Crowder and Nett, 1984) and hamster (Adams et al., 1981), with levels declining
following the LH surge. In beef heifers, pituitary GnRHR concentrations were highest at
estrus, declined by Day 7, then returned to estrus levels by Day 14 (Schoenemann et al.,
1985). In contrast, Nett and associates (1987) reported that levels of GnRHR in beef
heifers did not change on Day 6 through 18 following estrus. There was a significant
decrease in receptor numbers from Day 19 through 21 which may be attributed to down-
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regulation of receptors by increased GnRH pulse frequency.
The physiological changes observed in the number of GnRHRs in the anterior
pituitary gland may be due to an increase in mRNA levels as changes in levels of GnRHR
mRNA preceded changes in protein levels (Kakar et al., 1994). In rats, levels of GnRHR
mRNA were highest on the afternoon of proestrus and coincided with a time when
numbers of GnRHRs are high and GnRH sensitivity is greatest (Bauer-Dantoin et al.,
1993). In contrast, treatment with an antagonist of GnRH had no effect on GnRHR
mRNA levels during the luteal period. The highest levels of GnRHR mRNA were
observed one day prior to estrus in the ewe. Levels of GnRHR mRNA declined 60 and
80% during the LH surge and 24 h following estrus, respectively, which closely
resembled reported levels of GnRHR (Padmanabhan et al., 1995). There was a 40%
reduction in GnRHR mRNA levels in female rats 36 h following ovariectomy (Yasin et
al., 1995). By 48 h, however, GnRHR mRNA levels had returned to pre-ovariectomy
levels, and continued to increase through Day 7.
In mice, ovariectomy decreased the binding of GnRH in the anterior pituitary
gland (Naik et al., 1985). A decrease in GnRHR was initially detected 12 h following
ovariectomy (Naik et al., 1984). The decline was followed by a brief increase in GnRHR
numbers at 24 h, then a progressive decline through Day 7 post ovariectomy. Long term
ovariectomy resulted in a 60% decrease in binding capacity (number of receptors
available for binding) compared to intact controls at 2 weeks and was sustained through 2
months. Likewise, rats immunized against GnRH had significantly reduced levels of
GnRHR (Popkin and Fraser, 1985). However, pituitary GnRHR levels were not
completely abolished by long-term immunization to GnRH, indicating an independent
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basal level of GnRHR regulation exists.
The suppression of GnRH during lactation due to the suckling response causes a
reduction in the amount of GnRHRs available. Levels of GnRHR mRNA in rats were
reduced during lactation compared to animals that were ovariectomized (Funabashi et al.,
1994). Similarly, compared to cycling female mice, the GnRHR concentration in the
anterior pituitary glands of lactating females was reduced by 40% (Naik et al., 1984).

GnRH II and GnRH II Receptor
Structure. In addition to well-characterized, mammalian GnRH, a second form,
Type II GnRH, was isolated in the chicken (Miyamoto et al., 1984). Type II GnRH
(GnRH II; pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2) is highly conserved among
species, and differs from Type I GnRH (GnRH) at positions 5, 7 and 8 (Wang et al.,
2004). The reason for such a high level of conservation is not known, as GnRH II is
identical in all species in which it has been discovered (White et al., 1998). The Type II
GnRH receptor (GnRH II-R) has been found in the catfish (Tensen at al., 1997), bullfrog
(L. Wang et al., 2001), primates (Lescheid et al., 1997; Millar et al., 2001) and marmoset
(Terasawa, 2003; Temple et al., 2003). The high level of conservation may be the result
of the ability of GnRH II to bind multiple receptors and differing structural requirements
for those receptors (Millar, 2003). It may also allow GnRH II to serve alternative
functions at different locations in the body (White et al., 1998).

In addition to primates,

the GnRH II-R has been identified in the pig (Neill et al., 2004) which is 91%
homologous to GnRH II-R in the monkey. Interestingly, an alternatively spliced 5transmembrane GnRH II-R has been discovered in pigs as well (Neill et al., 2004). This
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receptor is missing the first two transmembrane domains so that the extracellular Nterminal end is linked directly to transmembrane domain 3. Similar to the GnRHR, the
GnRH II-R signals via the Gq pathway (Tensen et al., 1997). Structurally, GnRH II-R
possesses a C-terminal tail that the GnRHR is lacking (Millar, 2003). The C-terminal tail
has been implicated in the rapid desensitization of the GnRH II-R. For example, when
treated with GnRH II the monkey GnRH II-R underwent desensitization whereas the
human GnRHR did not when treated with the GnRH agonist, triptorelin (Neill, 2002).

GnRH II Receptor Gene. The GnRH II-R gene has been identified in several
other species, however a functional, full-length mRNA has not been found. In sheep, the
GnRH II-R gene is located in a similar position in relation to other genes as the human.
The gene consists of three exons and two introns, but contains a premature stop codon in
exon 1, preventing functional GnRH II-Rs from being synthesized (Gault et al., 2004).
The human GnRH II-R gene contains two flaws that prevent it from being properly
translated (Neill et al., 2004). The first is a shift that eliminates a transcription start site
near the N-terminus. The second flaw is a single base substitution that changes the Arg
at position 179 to a premature stop codon that would terminate translation in exon 2
(Morgan et al., 2003). Likewise, in cattle and chimpanzees there is a shift in sequence
resulting in a premature stop codon (Morgan et al., 2003). In each case, the potential for
a full length protein is present; however the sequence shift would have to be overcome.

Distribution. A small amount of GnRH II has been found in the hypothalamus
with proximity to the hypothalamo-hypophyseal portal system in primates, but in greatly
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reduced amounts compared to GnRH (Lescheid et al., 1997).

However, most

gonadotropes in the anterior pituitary of the marmoset express both GnRHR and GnRH
II-R (Millar et al., 2001). Distribution of GnRH II receptor in the midbrain as well as
other extra-hypothalamic regions of the brain may be indicative of a neurotransmitter
involved in sex behavior (Terasawa, 2003).

Sexual receptivity increased in energy

restricted female musk shrews within minutes of treatment with GnRH II versus
untreated controls, potentially through actions at the GnRH II-R (Temple et al., 2003).

Receptor Affinity. There is little chance that GnRH has an effect at the GnRH
II-R, especially since GnRH was 400 times less active (Neill et al., 2004) and had 1/421
the potency (Neill, 2002) as GnRH II at the GnRH II-R. The difference in affinity for
each of the ligands at their respective receptors may be due to their amino acid content.
The Trp and Tyr at positions 7 and 8, respectively, may be responsible for affinity of
GnRH II to its receptor (Maiti et al., 2003). Modified GnRH containing the two residues
were able to interact with monkey GnRH II-R in a similar fashion as native GnRH II.
Also, similar to GnRH, substitution of a small D-amino acid, such as D-Ala in position 6
caused an increase in affinity of GnRH II for its receptor (Maiti et al., 2003).
Gonadotropin-releasing hormone II receptors have a high affinity for GnRH II and
promote higher stimulation of inositol phosphate production following binding GnRH IIR than GnRH (Millar et al., 2001). It is also interesting to note that some GnRH
antagonists act as agonists at GnRH II-R, potentially due to conformational changes
following the ligand binding the receptor activating alternative signaling cascades.
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Function. The function of GnRH II and its receptor are not well known, but
several hypotheses exist. One thought is that GnRH II may play a role in the control of
the gonadotropins, specifically with preferential stimulation of FSH secretion (Yu et al.,
1997). Evidence for this is found in the chicken (Millar et al., 1986) and male sheep
(Millar et al., 2001). However, in male rhesus monkey pituitary cell cultures, GnRH II
stimulated LH and FSH release over basal levels, but was less effective than GnRH.
Okada and associates (2003) also found that the potent GnRH antagonist, antide, blocked
GnRH II stimulated secretion of LH and FSH. A similar level of gonadotropin release, as
well as blockade of stimulated gonadotropin secretion by antide, was also seen in female
monkeys (Densmore and Urbanski, 2003). It was also noted that GnRH II did not
enhance gonadotropin secretion when added to cultures concurrently treated with GnRH,
implying that GnRH II does not act on GnRHR (Okada et al., 2003).
When treated with GnRH II or an agonist of GnRH II, mRNA levels for both
GnRHR and GnRH II were down-regulated in human granulosa-luteal cells (Kang et al.,
2001). In contrast, treatment with FSH and hCG yielded dose-dependent increases in
GnRH II mRNA levels, but decreased GnRH I mRNA levels. Kang and associates
(2001) also reported that GnRH II caused a decrease in FSH and LH receptor mRNA
levels. It appears that GnRH and GnRH II are differentially regulated by their response
to levels of homologous ligand (biphasic reaction of GnRH and down-regulation of
GnRH II).

SB-75 (Cetrorelix)
Also known as Cetrorelix, the specific GnRH antagonist, SB-75, ([Ac- D -
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Nal(2)1,D-Phe(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]GnRH) displays a strong affinity for the
GnRHR. The GnRH antagonist, SB-75, not only occupies GnRH binding sites, but can
also down-regulate GnRHR concentration (Halmos et al., 1996). Halmos and associates
(1996) treated male rats with a single 100 μg dose of SB-75, which reduced the number
of binding sites as determined by receptor binding assay. Using desaturation methods, it
was reported that the decrease in binding was associated with SB-75 down-regulation of
GnRHRs and not simply occupancy. The down-regulation persisted for at least 72 h.
The antagonist, SB-75, does not, however, have an effect on GnRH II-R signaling
activity (Neill, 2002). In male rats, a single treatment of SB-75 decreased membrane
GnRHR concentration within 2 h following administration. The maximum effect of SB75 was attained by 6 h (83% reduction), and levels of GnRHR were significantly reduced
for greater than 48 h (Halmos and Schally, 2002). This is in agreement with a previous
study in which SB-75 treatment decreased GnRHR levels in male rat anterior pituitary
membranes by 82% with no effect on affinity (Pinski et al., 1996).

Additionally,

treatment with SB-75 in castrate male rats caused an 80% reduction in LH levels by 24 h.
Levels of LH remained low for 72 h, but returned to pre-treatment levels by 96 h posttreatment (G. Jiang et al., 2001). Chronically treated animals also had a decline in
GnRHR concentration with the greatest reduction observed on Day 14 of treatment (86%
reduction). The single injection and chronic treatments maximally decreased GnRHR
mRNA levels nearly 27% and 35%, respectively (Halmos and Schally, 2002). Halmos
and Schally also looked at GnRHR numbers in nuclear extracts of the same samples and
found an opposite effect of SB-75 treatment. There appears to be an inverse relationship
between amounts of GnRHR in nuclear and membrane extracts, possibly due to
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internalization and translocation of bound GnRHRs. Treatment with SB-75 caused
female rats to remain in a state of perpetual diestrus for the duration of a 30-day
treatment.

Additionally, LH levels declined by 80%, and there was a decrease in

estrogen, progesterone and GnRHR over the duration of the treatment (Horvath et al.,
2002). Horvath and associates (2002) also demonstrated that levels of GnRHR protein
increased following ovariectomy, but SB-75 treatment for 10 d decreased the elevated
levels by 84%.
In many in vivo experimental studies, endogenous GnRH competes for binding
with the analogue being tested. To demonstrate the effectiveness of persistent analogue
treatment, male rats were treated daily for four weeks with either saline, a GnRH agonist
([D-Trp6]-GnRH), or a GnRH antagonist (SB-75). Next, rats were challenged with a
single intravenous injection of GnRH.

Levels of LH increased within 10 minutes

following challenge in control and agonist treated groups. Levels of LH continued to rise
after 30 minutes in the control animals and, at a significantly reduced rate (~45%
inhibition), in the agonist-treated group. Levels of LH released in the SB-75 treated
group were significantly less than control and agonist-treated groups (~80% inhibition).
Likewise, levels of GnRHR were reduced in both agonist and SB-75-treated groups by
68% and 82%, respectively (Pinski et al., 1996). From these results, it appears that
chronic administration of a GnRH agonist or antagonist desensitizes gonadotropes to
GnRH stimulation, via down-regulation of GnRHR.

Gonadotropins and Gonadotropin Subunits
General. The gonadotropins are heterodimeric glycoproteins each sharing a
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common α-subunit; however it is the individual β-subunits that give FSH and LH
biological specificity. Secretion of the gonadotropins, FSH and LH, is controlled by
GnRH. Pulses of LH are a result of, and mimic, GnRH (Padmanabhan et al., 2003) and
GnRH is immensely responsible for both basal and pulsatile LH release (Esbenshade et
al., 1986). Interestingly, while most GnRH pulses (90% in ovariectomized and 70% in
luteal phase ewes) produced an FSH pulse, pulses of FSH were also observed in absence
of a GnRH pulse.

In addition, Padmanabhan and associates found FSH pulses in

hypothalamo-hypophyseal portal blood that was not associated with GnRH stimulation,
and that episodic patterns of FSH secretion continued after treatment with a GnRH
antagonist, suggesting an alternate non-GnRH component of FSH release.

Effect of GnRH Pulsatility. Frequency of GnRH pulses produces differing
gonadotropin responses (Jayes et al., 1997). In GnRH immunized gilts, a high pulse
frequency (every 30 minutes) of a non-cross-reactive GnRH agonist produced a greater
response in LH release than FSH. However, after three days of treatment, both LH and
FSH had been desensitized to GnRH. Low frequency (every 180 minutes) pulses of
GnRH did not increase LH levels, but was at an effective level to maintain FSH
production. Further, low frequency pulses of GnRH did not cause the desensitization to
GnRH by FSH and LH secretion that was observed with high frequency pulsation. In
both groups, a bolus injection of GnRH administered on the third day of treatment
resulted in an inverse relationship between pulse frequencies of GnRH and response to
the bolus, further showing desensitization in the high pulse group (Jayes et al., 1997). In
another study, continuous infusion of GnRH caused an initial increase (2 h) in LH,
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followed by a gradual decrease to baseline levels (~20 h) in ewes (Nett et al., 1981).
Levels of FSH initially increased (2 h) during the infusion period but, unlike LH, levels
of FSH diminished quickly to baseline (5.5 h) followed by a further 70% decrease below
baseline (14 h).
Pulse and pattern of GnRH stimulation differentially regulates expression of the
common α-glycoprotein, and specific FSHβ- and LHβ-subunits (Haisenleder et al., 1991).
To demonstrate the effect of GnRH pulse frequency on gonadotropin subunit expression,
gonadotrope-derived LβT2 cells were treated with pulses at 30 minutes and 2 h. The
greatest expression of the LHβ-subunit gene was observed at a GnRH pulse frequency of
every 30 minutes; however the FSHβ-subunit was maximally stimulated at the lower
pulse frequency of GnRH (2h; Bédécarrats and Kaiser, 2003). Levels of the α-subunit
were expressed at all levels with less dependence on GnRH pulse frequency.

Effect of GnRH Receptor on Subunit Expression. The transcriptional response
of the gonadotropic subunits due to GnRH stimulus is influenced by the amount of
GnRHR expressed (Kaiser et al., 1995). Levels of LHβ- and α-subunit activity were
increased by GnRH proportionally to the number of GnRHRs. In contrast, the FSHβsubunit was most favorably stimulated at low levels of GnRHR gene expression.
Differential regulation of the FSHβ- and LHβ-subunits was also observed in LβT2 cells
where an increase in GnRHR levels specifically inhibited FSHβ-subunit gene promoter
stimulation (Bédécarrats and Kaiser, 2003).

This suggests that regulation of the

gonadotropin subunits by GnRH may differ at low vs. high levels of GnRHR. Kaiser and
associates (1995) suggested that factors, such as GnRH pulse frequency, may regulate the
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amount of GnRHR expressed on the gonadotrope cell surface, which in turn regulates
expression of the gonadotropic subunits, potentially through different signaling pathways.
At low GnRHR numbers, all three gonadotropin subunit genes are expressed. However,
at high levels, an inhibitory effect is seen on FSHβ-subunit gene expression only,
substantiating the theory that the subunits may be regulated by different signal
transduction pathways.
Mutations in the human GnRHR cause alterations in expression of the
gonadotropin subunits. Stimulation with GnRH resulted in an 8-fold reduction in LHβsubunit gene promoter activity when mutations occurred at positions 106 (Arg for Gln in
first extracellular loop) and 262 (Gln for Arg in third intracellular domain) of the human
GnRHR (Bedecarrats et al., 2003). The mutations caused a decrease in GnRH
responsiveness of FSHβ-subunit gene promoter activity by 14 and 15-fold, and α-subunit
gene promoter activity by 3.8 and 10.6-fold for the 106 and 262 mutations, respectively.
This is interesting considering the effects on FSHβ- and LHβ-subunit gene expression of
the mutations are fairly equal, whereas the two mutations cause differential effects to αsubunit expression. The differential effects of the mutations are also observed in GnRHR
gene promoter activity with the 106 and 262 mutations decreasing GnRHR gene
promoter activity by 2.2- and 3.7-fold, respectively. Bedecarrats and associates (2003)
also observed that the wild-type FSHβ-subunit gene had a greater sensitivity to GnRH
stimulation than the LHβ- or α-subunit genes, suggesting the FSHβ-subunit gene is more
sensitive to intracellular signaling, or is regulated by a different signaling pathway.
There was also a decrease in sensitivity of the ERK pathway in the mutated GnRHR, with
a greater effect of the 262 mutation. Evidence for stimulation of different signaling
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pathways by GnRH is also indicated by the differential effects of GnRH on both the αsubunit and GnRHR genes. Though there were differing responses to GnRH stimulation
by the α-subunit and GnRHR genes, levels of inositol phosphate were similarly decreased
in both mutant receptors, further suggesting the action of multiple pathways.

Differential Regulation of Gonadotropin Subunits. Using cultured α-T3 cells,
Chedrese and associates (1994) demonstrated a stimulatory effect of GnRH on
transcription of the glycoprotein hormone α-subunit gene, as well as mRNA stability.
Interestingly, GnRH caused a temporary increase in transcription, but levels of α-subunit
mRNA remained stable during the time of transcriptional decline. In the absence of
GnRH or with the addition of the GnRH antagonist, antide, levels of α-subunit mRNA
declined rapidly. It was determined that in the presence of GnRH, the half-life of αsubunit mRNA increases 6.7-fold (Chadrese et al., 1994). This demonstrates that the
presence of GnRH not only increases the amount of α-subunit gene transcription but also
plays a part in decreased degradation of α-subunit mRNA.
To further substantiate differential regulation of gonadotropin subunit genes,
levels of α- and LHβ-subunit mRNA in the rat did not increase significantly until Day 3
following ovariectomy, then continued to rise through Day 7 (Burger et al., 2001). In
contrast, levels of FSHβ-subunit gene expression were elevated above starting levels by
12 h following ovariectomy, with another significant increase by Day 3. Serum levels of
FSH and LH followed the pattern of their respective subunits. Treatment with a GnRH
antagonist eliminated the increase in α-glycoprotein and LHβ-subunit mRNA, and
decreased, but did not abolish, the increase seen in FSHβ-subunit gene expression
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following ovariectomy.
In addition to regulation by GnRH, the FSHβ-subunit gene is positively regulated
by activin (Weiss et al., 1992), while steroids have a negative action on expression.
Further, treatment with an inhibin antagonist had no effect on LHβ, but caused an
increase in FSHβ mRNA levels 12 h following ovariectomy, suggesting that factors other
than GnRHR also have an effect on the subunit genes. This differential regulation of the
gonadotropic subunits creates the potential for differential secretion of the respective
gonadotropins.

Role of Subunits in Secretion of Gonadotropins. Luteinizing hormone appears
to be stored intracellularly and secreted in a regulated manner (facilitating the
preovulatory LH surge), while FSH is released in a constitutive manner (Muyan et al.,
1994). Brown and associates (2001) conducted an experiment to determine if expression
of FSHβ- and LHβ-subunit genes contributed to the differential patterns of FSH and LH
storage and secretion.

This was accomplished by creating transgenic mice with a

truncated ovine FSHβ-subunit gene encoding an mRNA lacking the 3’ untranslated
region and driven by the ovine LHβ-subunit gene promoter. Two lines of mice were used
in this study, an FSHβ deficient (dFSH) line and a line deficient in both FSH and inhibin
(dFI). Both lines of mice were infertile. Expression patterns of ovine FSHβ mRNA were
similar to the murine LHβ, but not murine FSHβ. Although the expression profile of
FSHβ mRNA was manipulated to mimic that of LHβ, only increased levels of FSH were
observed, with no changes in storage properties.

This indicates that regardless of

synthesis, post-translational modifications promote the storage of LH and release of FSH
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from the anterior pituitary gland. Substitution of the LHβ-subunit promoter for the
FSHβ-subunit promoter diminished the transcriptional response to steroids and removed
inhibin responsiveness. This suggests there are elements within the promoter region of
the FSHβ gene that are responsible for regulating the level of FSH synthesis. There was
an increased ovulation rate in the dFSH line that was not observed in the dFI line. The
increase ovulation rate was attributed to differential post-translational glycosylation of
FSH between the dFSH line, which had higher glycosylation levels, and the dFI line. The
glycosylation in the dFSH line may cause the half-life of FSH to increase, exposing the
ovary to higher levels of FSH for a longer period of time. The increased ovulation rate
could be due to increased follicular recruitment or decreased follicle atresia.

Hormonal Influence on GnRH Receptor, Gonadotropins and Their Subunits
Estradiol-17β.

Estradiol-17β from preovulatory follicles stimulates the LH

surge, as well as the onset of estrus, which in turn stimulates the final maturation and
ovulation of follicles in the pig (Van de Wiel et al., 1981). It appears that stimulation of
the LH surge occurs as estrogen reaches and maintains a particular threshold level. Britt
and associates (1991) hypothesized that estradiol-17β blocks endogenous GnRH
secretion through negative feedback allowing LH to accumulate in the anterior pituitary
until a time that positive GnRH feedback causes the LH surge to occur. Initially, it
appears estradiol reduces responsiveness of GnRHRs to GnRH leading to a reduction in
secretion of GnRH for a period of time. This is followed by positive feedback from
pulses of GnRH as estradiol-17β levels decline. The ensuing LH surge is proportional to
the amount of GnRH stimulation on the anterior pituitary gland.

Thus, negative
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inhibition by estradiol-17β allows LH stores to build within the anterior pituitary
facilitating the preovulatory LH surge when GnRH stimulation is returned.
Follicle stimulating hormone appears to act in an opposite fashion as estradiol17β. When levels of FSH are increased, such as the time prior to the preovulatory LH
surge and following ovulation, estradiol-17β levels decrease. As FSH levels begin to
decrease in the pig on Day 3 following the LH surge, estradiol-17β levels begin to rise.
Increased estradiol-17β secretion during follicle maturation coincided with a decrease in
FSH secretion in gilts (Guthrie and Bolt, 1985).

In cows, prolonged exposure to

estradiol-17β stimulated primordial follicles to be activated (Cushman et al., 2001). As
follicles begin to grow following FSH exposure, estradiol-17β production in those
follicles increases, suppressing FSH and preventing further follicle growth (Van De Wiel
et al., 1981). In a study by Baratta et al. (2001), a parallel decline in mRNA for FSHβ
and activin βB was observed in ovine pituitary cells treated with estradiol-17β. These
data suggest that the decline in FSH coinciding with increased estradiol-17β is caused, in
part, by inhibition of activin βB production. Consistent with this, a putative estrogen
response element has been identified in the 3’-untranslated region of the human activin
βB gene (Mason et al., 1989).
Estradiol-17β also has an effect on GnRHR regulation. Estradiol-17β functions to
increase the number of GnRHRs through actions at the anterior pituitary gland in a time
and dose dependent manner (Gregg et al., 1990). Clayton et al. (1980) hypothesized that
cyclic levels of estradiol-17β stimulated GnRH release from the hypothalamus, inducing
GnRHR up-regulation as well as a subsequent hypothalamic GnRH release. In ovine
pituitary cultures, GnRHR levels increased 30 to 40 fold following a 48-hour estradiol-
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17β treatment (Laws et al., 1990). An increase in number of GnRHRs was also seen in
ovariectomized cattle treated with estradiol-17β (Looper et al., 2003). In rats, there is an
increase in GnRHR mRNA after estradiol-17β treatment which appears to occur due to
an increased number of gonadotropes expressing GnRHR mRNA, as determined by in
situ hybridization (Quiñones-Jenab et al., 1996). A study of ovine pituitary cultures
indicated similar results, as estradiol-17β treatment alone increased GnRHR mRNA
190% over controls and this increased to 400% when treated in combination with inhibin
(Wu et al., 1994).
In contrast, Cheon and co-workers (2000) found that estrogen had no effect on
basal expression of GnRHR mRNA in primary rat pituitary cell cultures. When treated
with GnRH, there was homologous up-regulation, but no additional increase with
estradiol-17β treatment. Addition of progesterone diminished the upregulation by GnRH
and coincubation with estradiol-17β did not rescue the loss. Kakar et al. (1994) found
increased GnRHR mRNA levels in rats 28 days after ovariectomy. Upon estradiol-17β
treatment, the level of GnRHR mRNA decreased, indicating a negative relationship
between estradiol-17β and GnRHR gene expression. Quiñones-Jenab (1996) postulated
that prolonged ovariectomy may stifle the effect of estradiol-17β on GnRHR stimulation
following long periods of absence. This is further substantiated by work in gilts (Stickan
et al., 1999), where 100 day post-ovariectomy gilts did not respond to estradiol-17β
treatment. It has also been noted in wethers that under physiological concentrations,
estradiol-17β can increase steady state levels of GnRHR mRNA, whereas chronic levels
of estradiol-17β may desensitize the pituitary and cause the opposite effect (Adams et al.,
1996).
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In ovariectomized ewes subjected to hypothalamic-pituitary disconnection (HPD),
treatment with estradiol-17β elicited no effect on LH, whereas intact control animals
exhibited LH patterns that resembled the pre-ovulatory LH surge (Gregg et al., 1989). In
the study by Gregg and associates (1989), estradiol-17β stimulated an increase in the
number of GnRHR in the HPD group, increasing 2-fold over control animals, without
hypothalamic input in the form of GnRH. Thus, estradiol-17β can increase the number of
GnRHRs on gonadotropes by acting on the hypothalamus to increase GnRH secretion. In
addition, estradiol-17β can stimulate the anterior pituitary gland to increase the number of
GnRHRs, thereby increasing sensitivity to GnRH.

Progesterone. Progesterone, released from luteal cells provides strong negative
feedback at the level of the hypothalamus to reduce GnRH secretion (Senger, 1999) and
GnRHR expression (Turzillo et al., 1994). Progesterone decreased homologous upregulation of GnRHR mRNA expression in rat pituitary cell cultures (Cheon et al., 2000).
In ewes, an increase in GnRH binding to GnRHR was not observed until progesterone
levels had reached baseline (Crowder and Nett, 1984). Female rats had a decrease in
GnRHR levels due to progesterone present during proestrus (Witcher et al., 1984). In
another study with sheep, an increase in GnRHR number appeared to require removal of
negative feedback by progesterone and stimulation by estradiol-17β (Kirkpatrick et al.,
1998). Turzillo et al. (1994) found that declining progesterone levels were followed by
an increase in the number of GnRHR, but occurred before levels of estradiol-17β had
begun to increase. This suggests that estradiol-17β may increase GnRH binding sites
during proestrus, but a decrease in progesterone levels may be needed before the increase
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can occur.
Gilts fed a progesterone agonist developed a pool of medium-sized follicles which
failed to mature, preventing estrous behavior and blocking the preovulatory LH surge
(Guthrie and Bolt, 1985). Female mice lacking the hepatic lipase gene had a reduction in
litter size as a result of decreased ovulation rate due to reduction in progesterone
production (Wade et al., 2002).
steroidogenesis.

Hepatic lipase provides cholesterol substrate for

Wade and associates (2002) postulated that the reduction in

progesterone production due to lack of substrate reduced the amount of follicles that
underwent final maturation. This was apparently due to a high number of non-ovulatory
follicles present following hCG stimulation.
In addition to its effects on GnRHR regulation, progesterone increased levels of
mRNA for LHβ in cultured rat pituitary cells (Park et al., 1996), but had no effect on
mRNA levels for the other gonadotropic subunits (Looper et al., 2003). The increase in
LHβ mRNA levels in rat pituitary cell cultures was caused by progesterone suppression
of RNA degradation (Park et al., 1996).

When treated with actinomycin D, an inhibitor

of transcription, levels of LHβ mRNA decreased by 30% compared to controls. Cells
treated with progesterone alone or progesterone and estrogen in combination were able to
suppress the degradation of LHβ mRNA, indicating that progesterone is capable of
modulating LHβ turnover rate.

Inhibin. Inhibin, produced and released by granulosa cells of the follicle, acts on
the anterior pituitary gland to inhibit FSH secretion. In this manner of negative feedback,
inhibin regulates the levels of circulating FSH. Basal release of FSH was suppressed by
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inhibin but had no effect on LH release in rat primary pituitary cell cultures (Braden et
al., 1990). Inhibin did not affect the basal rate of GnRHR synthesis, but did interfere
with the stimulatory effect of GnRH on GnRHR synthesis.
Medan et al. (2003a) demonstrated that goats could be superovulated through
passive immunization to inhibin. Upon immunization, levels of plasma FSH increased
whereas LH levels remained unchanged. Animals passively immunized against inhibin
also had an earlier preovulatory FSH surge with a higher peak when compared to
controls. It appears that, after negative feedback from inhibin is eliminated, the increased
level of FSH present stimulates the development of a new cohort of small follicles.
Increased levels of FSH influenced follicular recruitment and development, resulting in
growth of several more follicles and a subsequent increase in ovulation rate. In another
study by Medan et al. (2003), active immunization to inhibin resulted in a positive
correlation between levels of inhibin antibody titres and ovulation rate.
Inhibin immunization resulted in an increased number of developing and ovulated
follicles in immature, 26-day-old mice compared to adult cyclic mice. Decreased levels
of other negative regulatory factors in immature mice that influence gonadotropin release,
such as estradiol-17β, could provide an explanation for the increased number of follicles.
This finding indicates that immature mice have a functional negative feedback control
system in place to regulate pituitary FSH secretion by inhibin (H. Wang et al., 2001).
However, as FSH was not measured, it is not possible to determine if increased levels of
FSH were responsible for the increase in the number of
follicles observed in immature mice.
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Homologous Regulation of the GnRH Receptor
GnRH Effects on GnRH Receptor Numbers.

In vitro studies have

demonstrated that GnRH can alter the number of pituitary GnRHRs (Loumaye and Catt,
1982). Changes in the number of GnRHRs can cause changes in pituitary responsiveness
to GnRH (Clayton et al., 1980). Cultured rat pituitary cells treated with GnRH had a
40% decrease in binding capacity in the first hour of treatment which returned to baseline
by 4 h, followed by an increase in binding sites after 6 h (Loumaye and Catt, 1983). To
determine what caused the increase in binding sites following down-regulation, the cells
were treated with cycloheximide, a protein synthesis inhibitor. Treatment prevented the
increase in binding sites as seen in the prior experiment, indicating that synthesis of new
GnRHR was needed to increase binding sites following desensitization. In another study,
continuous infusion of GnRH caused an initial increase in the number of GnRHRs after 4
h, followed by a decrease to 70% (12 h) and 50% (24 h) of the pre-treatment value (Nett
et al., 1981). Nett and associates (1981) postulated that the decrease in GnRHR numbers
was an inert system to compensate for an affluence of GnRH.

Transcriptional vs. Translational Regulation.

Homologous regulation of

GnRHRs by GnRH could be controlled by changes in mRNA levels (transcriptional) or
amount of protein being produced (translational). Cheon and associates (2000a) further
explored GnRHR autoregulation using both transcriptional and translational inhibitors in
pituitary cell cultures to determine: 1) if homologous up-regulation requires new RNA
synthesis, 2) if homologous up-regulation requires new protein synthesis, and 3) the
effect of GnRH on basal turnover of GnRHR mRNA. Adding GnRH to pituitary cells
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caused an increase in both GnRHR mRNA and LH levels after 6 h. The transcriptional
inhibitor, actinomycin D, had no effect on the level of GnRHR mRNA or LH production.
However, when actinomycin D and GnRH were added simultaneously, the GnRH
induced increase in GnRHR mRNA was lost and LH levels were also reduced. Using an
inhibitor to protein synthesis, cycloheximide, Cheon and co-workers (2000a) reported
there was no effect on basal expression or the GnRH-induced increase in GnRHR mRNA
levels. Luteinizing hormone levels were similar to those in pituitary cells treated with
actinomycin D. Thus, it appears that homologous regulation of the GnRHR gene occurs
at transcription.
Similarly, female rats receiving a sustained-release of a GnRH antagonist had a
reduction in GnRHR mRNA over a four week period, and the level of GnRHR mRNA
was still significantly lowered at eight weeks (Sakakibara et al., 1996). Treatment with
GnRH or a GnRH agonist caused a biphasic response in GnRHR mRNA in human
granulosa-luteal

cells;

low concentrations

caused

up-regulation

whereas high

concentrations resulted in down-regulation (Kang et al., 2001). In the ewe, numbers of
GnRHR increased following an increase in GnRHR mRNA (Turzillo et al., 1994). In
αT3-1 cells, exposure to GnRH reduced the amount of GnRHRs, as well as level of
GnRHR mRNA in a time- and dose-dependent manner (Mason et al., 1994). Northern
blot analysis revealed that treatment with D-Ala6-GnRH stimulated mouse GnRHR
mRNA. Maximal stimulation was achieved at 4 h in α-T3-1 cells, after which levels of
GnRHR mRNA began to decline (Norwitz et al., 1999).
In contrast to the studies described above, Tsutsumi and co-workers (1993)
discovered that, with exposure to physiological levels of GnRH in a gonadotrope-derived
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cell line, the number of GnRHRs increased without a corresponding change in mRNA
levels. Thus, it did not appear that regulation of the GnRHR involved changes in gene
transcription, but rather augmented translational mechanisms. When GnRH was added to
primary pituitary cultures, there were trends toward suppression of GnRHR mRNA
turnover by increasing its half-life, as well as an increased stability of pre-existing mRNA
(Cheon et al., 2000a). Thus, stability of pre-existing mRNA may be important in the
regulation of steady-state levels. However, homologous up-regulation of GnRHR occurs
through transcriptional activation of the GnRHR gene rather than enhancement of the
stability of pre-existing mRNA.

Cell Signaling Pathways Involved in Transcriptional Regulation of the
GnRH Receptor Gene. It is known that GnRH binding to its receptor in gonadotropes
stimulates cell signaling through multiple pathways, however two pathways have
primarily been investigated.

The first pathway results in phospholipase C (PLC)

generation of diacyl glycerol (DAG) and inositol triphosphate (IP3), which activates
protein kinase C (PKC). The second cascade involved in GnRH signaling results in the
stimulation of cyclic andenosine monophosphate (cAMP).

Cell Signaling via Protein Kinase C.

The αT3-1 cell line is a mouse

gonadotrope-derived cell line that contains a lower number of GnRHR than gonadotropes
themselves and expresses GnRHR and the gonadotropin α-subunit (Kaiser et al., 1997).
Responsiveness of the GnRHR gene promoter to GnRH in this cell line is mediated
through activation of the PKC cellular signaling pathway. Activated PKC then signals
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through stimulation of the mitogen-activated protein kinase (MAPK) pathway which
ultimately cause an activating protein-1 (AP-1) complex to bind an element located
between -336 and -330 of the mouse GnRHR gene promoter (White et al., 1999). Others
have identified the same AP-1 binding site as a critical element for GnRH responsiveness
of the mouse GnRHR gene promoter in a position between -276 and -269 bp upstream of
the transcriptional start site, termed the sequence underlying responsiveness to GnRH-2
(SURG-2; Norwitz et al., 1999). Another element, SURG-1 (-292 to -285), was found to
be an enhancer element. Thus, SURG-2 is critical for responsiveness of the mouse
GnRHR gene to GnRH, but SURG-1 is necessary for the maximal response to GnRH
(Norwitz et al., 1999). In addition, the regulation of GnRH at the AP-1 site is associated
with JunD and FosB binding, as well as the c-Jun N-terminal kinase (JNK) signaling
cascade (Ellsworth et al., 2003). It is also interesting to note that changes in c-jun mRNA
levels closely resemble those of GnRHR mRNA in the ewe (Padmanabhan et al., 1995).
Individually buserelin, a GnRH agonist, and phorbol 12-myristate 13-acetate
(PMA), an activator of PKC, stimulated GnRHR gene promoter activity in GGH3 cells
(somatolactotrope cells stably transfected with the GnRHR gene; Kaiser et al., 1994)
transfected with a reporter vector containing 1226 bp of the mouse GnRHR gene
promoter, with the greatest stimulation from buserelin (Linn and Conn, 1999). However,
addition of PMA to buserelin-treated cells did not enhance GnRHR promoter activity.
Inhibition of the PKC pathway caused a decrease in basal levels and abolished
stimulation of the GnRHR gene promoter by both buserelin and PMA. Continuous
stimulation with PMA desensitized subsequent stimulation by buserelin and PMA, but
had no effect on cAMP, suggesting that a PKC-dependent pathway is involved in GnRH
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regulation of GnRHR gene promoter activity.

Cell Signaling via Protein Kinase A. Treatment of αT3-1 cells transfected with
the full length 5’ flanking region from the human GnRHR gene promoter with forskolin
induced a substantial increase in activation of the GnRHR gene promoter in a time- and
dose-dependent manner (Cheng et al., 2001). Forskolin causes increases in intracellular
cAMP production by adenylate cyclase activation. To further substantiate the cAMP
effect, treatment with cholera toxin (stimulates continuous adenylate cyclase activation)
and a cAMP agonist mimicked the stimulatory increase in GnRHR gene promoter
activity. Inhibition of protein kinase A (PKA) and adenylate cyclase reduced forskolin
stimulation of GnRHR gene expression (Cheng et al., 2001). This is in contrast to other
reports in which forskolin had no stimulatory effects on mouse GnRHR expression in
αT3-1 cells (Norwitz et al., 1999; White et al., 1999).
Cheng and associates (2001) also found potential AP-1/cAMP Response Element
Binding protein (CREB) binding sites (hGR-AP/cAMP Response Element-1 (CRE-1)
and hGR-AP/CRE-2) between -407 and -167 of the human GnRHR gene promoter.
Mutations of each site individually caused a reduction in forskolin-induced stimulation.
Interestingly, mutation of hGR-AP/CRE-1 caused a decrease in basal GnRHR gene
expression, while hGR-AP/CRE-2 causes an increase. Double mutation of both sites
caused a further reduction of forskolin stimulation, but had no effect on basal expression.
Using gel mobility shift assays, it was discovered that the first site binds only CREB,
whereas the second site binds AP-1 before, but CREB following, forskolin treatment. It
is presumed that forskolin activation increases the amount of CREB, allowing it to
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compete away AP-1 binding. This suggests that AP-1 suppresses basal activity of the
GnRHR gene promoter and binding of CREB changes the inhibitory regulation to a
stimulatory response.
Cholera toxin or cAMP treatment of GGH3 cells transfected with reporter vectors
containing 1226 bp of the murine GnRHR gene promoter stimulated GnRHR promoter
activity. Treatment with cAMP also enhanced the duration of buserelin stimulation of
GnRHR gene promoter activity (Lin and Conn, 1998). Treatment with a cAMP inhibitor
had no effect on basal promoter activity, but reduced the level of buserelin activation.
Thus, it appears that GnRH stimulates cAMP production and also activates transcription
of the GnRHR gene in part through stimulation of the cAMP signal transduction cascade
in GGH3 cells.
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CHAPTER III

General Materials and Methods

Animals
All animal procedures were conducted according to the University of Nebraska
Institutional Animal Care and Use of Committee. White crossbred gilts of both the Index
and Control lines (Generation 23) were transported to the UNL Animal Science Building
from the University of Nebraska Agricultural Research and Development Center (ARDC)
Swine Unit in Mead, Nebraska. Gilts of the Meishan breed were transported to the
Animal Science Building from the United States Department of Agriculture, Roman L.
Hruska U.S. Meat Animal Research Center in Clay Center, Nebraska. Gilts were housed
in pens with a minimum of 8 square feet of floor space, 4 pounds of feed per day and
water available ad libitum. Gilts of the Index and Control lines were detected for estrus
beginning at 155 days of age, whereas estrous detection began at 95 days of age for
Meishan females. Upon completion of the third (Index and Control) or sixth (Meishan)
estrus, ten gilts from the Index and Control lines, and 12 Meishan gilts (Table 3.1) were
ovariectomized during the luteal phase (Day 5 through 15 of the estrous cycle). Based on
a preliminary study in our laboratory and previous reports (Christenson et al., 1993;
Hunter et al., 1993), Meishan gilts do not exhibit an increased ovulation rate following
three estrous cycles when compared to gilts of occidental breeds. Thus, an additional
three estrous cycles were allowed for Meishan females to increase ovulation rate to a
level above that of control gilts. Moreover, ovulation rate in Meishan females continues
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TABLE 3.1. EXPERIMENTAL DESIGN
Breed
Treatment

Control

Index

Meishan

Control

n=5

n=5

n=6

SB-75

n=5

n=5

n=6
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to increase with age at a greater rate than observed in occidental breeds (Christenson et
al., 1993).

Surgical Procedures
Ovariectomies were performed in the surgical facility at the Animal Science
Building using procedures approved by the Institutional Animal Care and Use
Committee. Animals were anesthetized with 6 ml of a mixture of telazol, atropine,
rompun and ketamine (TARK) administered intramuscularly in the neck followed by 4
ml delivered intravenously in the ear. The composition of TARK and the time and
amount of other drugs administered for surgical procedures are presented in Table 3.2.
Once anesthetized, the incision site was prepared for surgery by washing with
warm water and removing hair. The site was then disinfected with three betadine washes
and 70% isopropyl rubbing alcohol, which also aided in drying. Feet were covered with
plastic O.B. gloves and restrained with rope. Nose tubes were inserted into each nostril
for administration of halothane and oxygen (3.5% and 0.7 L/min, respectively)
throughout the surgery. Gilts were given 3 ml of Polyflex (8.8 mg/kg; Fort Dodge
Animal Health, Fort Dodge, IA) and 2 ml of Banamine (2 mg/kg; Schering-Plough
Animal Health Corp., Union, NJ) following ovariectomy and one day post-surgery (Table
3.2).
Entry into the abdomen was facilitated by an incision into the skin at the midline.
Using gauze, the underlying fat was bluntly dissected revealing the linea alba. Next, an
incision was made through the abdominal wall at the linea alba. Upon entry into the
body cavity, one uterine horn was externalized to expose the ovary while the other
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TABLE 3.2. COMPOSITION OF TARK ANESTHETIC AND DOSE AND TIME OF
DRUG DELIVERY FOR SURGICAL PROCEDURES
Drug
Route
*Dose (mg/kg)
Telazol
I.M.
0.8
Atropine
I.M.
0.2
Rompun
I.M.
0.8
Ketamine
I.M.
3.1
Telazol
I.V.
0.5
Atropine
I.V.
0.1
Rompun
I.V.
0.5
Ketamine
I.V.
2.1
Halothane
Inhalation 3.5%
Ampicillin
I.M.
8.8
(Polyflex)
Banamine
I.M.
2.0
*Based on average body weight (114 kg or 250 lbs)

Special Instructions
Pre-operative in neck behind ear

Approximately 10 minutes post
I.M. in ear vein
During Surgery
Following Surgery + 1 day
Following Surgery + 1 day
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remained inside the body cavity to prevent drying, which may cause adhesions. The
reproductive tract was rehydrated with 5% glycerol saline on tissue that appeared
dehydrated. The ovary was located and grasped firmly, moving the fimbria away from
the ovarian body. Next, it was clamped between the ovary and the bursa of the oviduct
using a large, curved Rochester-Carmalt clamp. The clamp was raised by the surgical
assistant, and the blunt end of a large, one half circle, taper point needle threaded with #2
catgut was pushed through the end of the hilus with care made to avoid any blood
vessels. The catgut was then cut into two pieces and the suture was tied off by hand on
each side with a double knot, followed by three single knots. Each suture tied off
approximately one half of the hilus. Then, each suture was tied to circumnavigate the
hilus, thus tying off the entire hilus. The ovary was removed by cutting across the top of
the clamp, between the clamp and ovary, with a scalpel blade. Corpora lutea (CL) were
counted to determine ovulation rate and the ovary was placed in a 50-ml conical tube on
ice for later analysis. With the ovary removed, the clamp was relaxed to determine the
presence of bleeding. If no bleeding was found, the horn was rehydrated with 5%
glycerol saline and returned to the body cavity. The remaining ovary was removed in a
similar manner. When both ovaries had been removed, the body wall was closed using
an interrupted stitch with #2 catgut. The skin was then loosely sutured with #0 catgut
using a continuous mattress stitch. Animals were allowed to recover overnight and
returned to housing pens in the animal facility.

Treatments
Approximately three weeks (18-22 days) after ovariectomy, gilts from each line
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were randomly assigned to treatment groups.

Animals from each line received an

injection of either the specific GnRH antagonist, SB-75 (10 μg biologically active
compound per kg of body weight; UNL Protein Core Facility), or vehicle (0.9% saline) at
60, 36 and 12 hours prior to sacrifice. A timeline of experimental treatments is presented
in Figure 3.1.

Serum and Tissue Collection
Blood samples were collected via jugular venopuncture prior to ovariectomy and
the first injection. Gilts from the Index, Control, and Meishan lines were transported to
the UNL abattoir the morning of sacrifice. Animals were rendered unconscious by
electrical stunning followed by exsanguination. At this time, a blood sample and the
head were collected. The top of the skull was removed using a bone saw. Next, the
pituitary gland was removed and transferred to a sterile Petri dish using RNase free
utensils. The anterior and posterior pituitaries were separated and the anterior pituitary
was divided into quarters. One quarter was placed in a sterile 2-ml cryovial and snap
frozen in liquid nitrogen. The remaining three quarters of the pituitary (approximately 65
mg of tissue/quarter) were placed in RNAlater (Ambion, Inc., Austin, TX) and kept on
ice for later RNA extraction.

Radioimmunoassay
Following collection, blood samples were allowed to coagulate at 4°C for 24
hours at which time they were centrifuged at 1200 x g for 20 minutes at 4°C. Serum was
stored at -20°C until needed.
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Time Prior to Sacrifice
60 h

OVX,
Blood
Collection

36 h

12 h

Blood
Collection
SB-75 or vehicle

0

Blood
Collection,
Pituitary
Harvest

Figure 3.1. Timeline of ovariectomy, treatments, blood sampling and tissue collection.
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LH. Iodination grade porcine LH (AFP11043B, A.F. Parlow, National Hormone
and Peptide Program, Torrance, CA) was radioactively labeled with Na-125I using the
“controlled” chloramine-T method (Proudman and Wentworth, 1978). Chloramine-T
oxidizes 125I from an anionic to a cationic form (Parker, 1981). The cationic form of 125I
is then able to react with the aromatic ring of tyrosine residues in porcine LH. Briefly, 20
μl of 0.25M NaPO4 was added to 2.5 μg porcine LH in PBS buffer (pH 7.4). To this,
0.152 nmol of Na-125I was added followed by 5.5 μg of Chloramine-T (rate limiting
amount). The reaction was allowed to proceed with intermittent gentle mixing for 5
minutes, at which time 100 μl of Stop/Transfer solution (1% potassium iodide, 0.01%
bromophenol blue, 16% sucrose in 0.05M sodium phosphate buffer, pH 7.4) was added.
Finally, 200 μl of 25% BSA was added and the mixture was loaded onto a QAE
Sephadex 25 column (0.7 x 15 cm column packed with QAE Sephadex 25, equilibrated
with 2 ml of 2% BSA and flushed with 20 ml of 0.05 sodium phosphate buffer, pH 7.4).
Fractions of 0.5 ml were collected into 13 x 100 mm glass test tubes containing 1.5 ml of
PBS-0.1% gel (0.14M NaCl, 0.01M NaH2PO4, 0.001M Na2H2PO4, 0.1% NaN3, 0.1%
gelatin). Fractions were assessed by counting 10 μl of each for radioactivity using an
APEX Automatic Gamma Counter (ICN Micromedic Systems, Horsham, PA). The first
three fractions with significant counts were used to set a binding check (typically
fractions 6-8). The amount of each fraction needed to achieve 18,000 cpm/100 μl was
determined. Next, calculations were performed to make primary and secondary antibody
solutions. The primary antibody was rabbit anti-porcine LH (A.F. Parlow, National
Hormone and Peptide Program, Torrance, CA) and stored at a 1:50 dilution. A working
dilution of 1:210,000 was utilized for the assays. The secondary antibody was donkey
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anti-rabbit gamma globulin (dARGG; Fitzgerald Industries, Concord, MA) with a
working solution of 10.5% dARGG, 0.5% normal rabbit serum (Pel-Freez Biologicals,
Rogers, AR) and 89% PBS-0.1% gel. For each fraction, tubes to determine total counts
(TC), non-specific binding (NSB) and specific binding (Bø) were labeled and prepared
(Table 3.3). Each of the TC tubes contained only 100 μl

125

I-pLH at approximately

18,000 cpm/100 μl of their respective fraction. The NSB tubes contained 600 μl of PBS0.1% gel and 100 μl
125

125

I-pLH. The Bø tubes contained 500 μl of PBS-0.1% gel, 100 μl

I-pLH, and 100 μl primary antibody.

Tubes were allowed to incubate at room

temperature overnight (approximately 14 hours). The secondary antibody was prepared
and allowed to precipitate overnight at room temperature. The following morning, the
secondary antibody was centrifuged at 1500 x g for 30 minutes. The supernatant was
poured off and the pellet resuspended in the original volume of PBS-0.1% gel. To each
of the NSB and Bø tubes, 100 μl of resuspended secondary antibody was added and the
mixture was allowed to incubate 1 hour at room temperature. Following incubation, 1 ml
of ice cold PBS buffer (pH 7.4) was added to the NSB and Bø tubes. The tubes were
then centrifuged at 2280 x g for 45 minutes at 4°C.

Following centrifugation, the

supernatant was poured off and the tubes were counted for radioactivity. Binding activity
was determined by the equation:
((Bø -NSB)/(TC))*100 = % binding
Serum levels of LH were measured using a double antibody immunoprecipitation
method adapted from Niswender et al. (1970). Levels of LH were determined using an
antiserum directed against porcine LH (Lot# AFP15103194Rb, A.F. Parlow), highly
purified, iodinated porcine LH as labeled hormone, and a standard prepared from
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TABLE 3.3. TUBE COMPONENTS FOR PORCINE LH RADIOIMMUNOASSAY

Tube

PBS-0.1% gel
buffer

TC
NSB
Bø
Standard
Unknown

--600 μl
500 μl
400 μl
300 μl

125

I

100 μl
100 μl
100 μl
100 μl
100 μl

Primary
antibody
----100 μl
100 μl
100 μl

Standard
or
Sample
------100 μl
200 μl

Secondary
antibody
--100 μl
100 μl
100 μl
100 μl
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AFP11043B (A.F. Parlow). The assay for porcine LH was validated as follows. Serial
dilutions of two independent porcine serum samples were assayed at volumes ranging
from 25 to 400 μl.

Assay determinations of these dilutions from each of the two

independent samples were highly correlated (r = 0.95). Parallelism was determined using
the Allfit program (DeLean et al., 1978). Slopes of plasma dilutions and the standard
curve were not significantly different (P > 0.40).
Assays were performed using the fraction with the highest binding from the
binding check. Prior to each assay, a protocol sheet was prepared that identified the tube
number pertaining to each sample. The TC, NSB and Bø were prepared as previously
described. The standard curve consisted of a porcine LH standard at concentrations of
0.0312, 0.0625, 0.125, 0.25, 0.5, 1.0, 2.0, 3.5 and 5.0 ng/ml. The assay also contained
controls of low and high LH serum, as well as pooled serum used to determine intraassay
coefficients of variance. To each tube, 100 μl of standard or 200 μl of serum was added
with the appropriate amount of PBS-0.1% gel to attain a total volume of 500 μl. To all
but TC and NSB tubes, 100 μl of primary antibody (1:210,000) and 100 μl of

125

I-pLH

(approximately 18,000 cpm/100 μl) were added. The solution was allowed to incubate
for 48 hours at 4°C. The evening prior to addition, secondary antibody was prepared as
previously described. Following the 48 hour incubation, 100 μl of resuspended
secondary antibody was added to all tubes except the TC tubes. Tubes were mixed and
allowed to incubate an additional 24 hours. The reaction was stopped by adding 1 ml of
cold PBS buffer to all tubes except the TC tubes. Samples were then centrifuged at 2280
x g for 45 minutes at 4°C. Following centrifugation, the supernatant was poured off and
tubes were counted for radioactivity. Data were then analyzed using FOURFIT (Boyer
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and Grotjan, University of South Dakota School of Medicine, Vermillion, SD), a four
parameter logistic curve fitting program, to determine LH levels.

FSH. Iodination grade porcine FSH (AFP10640B, A.F. Parlow) was
radioactively labeled with Na-125I using a Chloramine-T/sodium metabisulfate reaction.
Chloramine-T oxidizes
cationic form of

125

125

I from an anionic to a cationic form (Parker, 1981). The

I is then able to react with the aromatic ring of tyrosine residues in

porcine FSH. Sodium metabisulfate then stops the reaction. Briefly, 0.152 nmol of Na125

I was added to 2.5 μg porcine FSH in 25 μl NaPO4 buffer (pH 7.4). To this, 14.82 μg

of Chloramine-T was added. The reaction was allowed to proceed with intermittent,
gentle mixing for 1 minute, at which time 34.8 μg of sodium metabisulfate was added to
stop the reaction. Next, 50 μl of Stop/Transfer solution was added and the mixture was
loaded onto a Sephadex G-25 column (0.7 x 15 cm column packed with Sephadex G-25,
equilibrated with 2 ml of 2% BSA and flushed with 20 ml of 0.05 sodium phosphate
buffer, pH 7.4). Fractions of 0.5 ml were collected into 13 x 100 mm glass test tubes
containing 1.6 ml of PBS-0.1% gel. Fractions were assessed by counting 10 μl of each
for radioactivity using an APEX Automatic Gamma Counter (ICN Micromedic Systems).
The first three fractions with significant counts were used to set a binding check
(typically fractions 4-6). The amount of each fraction needed to achieve 18,000 cpm/50
μl was determined. Next, calculations were performed to make primary and secondary
antibody solutions. The primary antibody was rabbit anti-porcine FSH (A.F. Parlow) and
stored at a 1:40 dilution. A working dilution of 1:300,000 was utilized for the assays.
The secondary antibody was dARGG (Fitzgerald Industries) with a working solution of
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15% dARGG, 0.5% normal rabbit serum (Pel-Freez Biologicals) and 84.5% PBS-0.1%
gel. For each fraction, tubes to determine total counts (TC), non-specific binding (NSB)
and specific binding (Bø) were labeled and prepared (Table 3.4). Each of the TC tubes
contained only 50 μl

I-pFSH at approximately 18,000 cpm/50 μl of their respective

125

fraction. The NSB tubes contained 600 μl of PBS-0.1% gel and 50 μl
Bø tubes contained 500 μl of PBS-0.1% gel, 50 μl

125

125

I-pFSH. The

I-pFSH, and 100 μl primary

antibody. Tubes were allowed to incubate at room temperature overnight (approximately
14 hours). The secondary antibody was prepared and allowed to precipitate overnight at
room temperature. The following morning, the secondary antibody was centrifuged at
1500 x g for 30 minutes. The supernatant was poured off and the pellet resuspended in
the original volume of PBS-0.1% gel. To each of the NSB and Bø tubes, 100 μl of
resuspended secondary antibody was added and the mixture was allowed to incubate 1
hour at room temperature. Following incubation, 2 ml of ice cold PBS buffer (pH 7.4)
was added to the NSB and Bø tubes. The tubes were then centrifuged at 2280 x g for 30
minutes at 4°C. Following centrifugation, the supernatant was poured off and the tubes
were counted for radioactivity. Binding activity was determined by the equation:
((Bø -NSB)/(TC))*100 = % binding
Serum levels of FSH were measured using a double antibody
immunoprecipitation method adapted from Niswender et al. (1970). Levels of FSH were
determined using an antiserum directed against porcine FSH (Lot# AFP2062096, A.F.
Parlow), highly purified, iodinated porcine FSH as labeled hormone, and a standard
prepared from AFP10640B (A.F. Parlow). The assay for porcine FSH was validated as
follows. Serial dilutions of two independent porcine serum samples were assayed at
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TABLE 3.4. TUBE COMPONENTS FOR PORCINE FSH RADIOIMMUNOASSAY

Tube
TC
NSB
Bø
Standard
Unknown

PBS-0.01M
EDTA, 1%
BSA buffer
--600 μl
500 μl
300 μl
300 μl

125

I

50 μl
50 μl
50 μl
50 μl
50 μl

Primary
antibody
----100 μl
100 μl
100 μl

Standard
or
Sample
------200 μl
200 μl

Secondary
antibody
--100 μl
100 μl
100 μl
100 μl
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volumes ranging from 12.5 to 200 μl. Assay determinations of these dilutions from each
of the two independent samples were highly correlated (r = 0.9985). Parallelism was
determined using the Allfit program (DeLean et al., 1978). Slopes of plasma dilutions
and the standard curve were not significantly different (P > 0.435).
Assays were performed using the fraction with the highest binding from the
binding check. Prior to each assay, a protocol sheet was prepared that identified the tube
number pertaining to each sample. The TC, NSB and Bø were prepared as previously
described. The standard curve consisted of a porcine FSH standard at concentrations of
50, 100, 200, 400, 800, 1600, and 3200 ng/ml. The assay also contained controls of low
and high FSH serum, as well as pooled serum used to determine intraassay coefficients of
variance. To each tube, 200 μl of standard or serum was added with 300 μl of PBS0.01M EDTA, 1% BSA (pH 7.5) to attain a total volume of 500 μl. To all but TC and
NSB tubes, 100 μl of primary antibody (1:300,000) and 50 μl of

125

I-pFSH

(approximately 18,000 cpm/50 μl) were added. The solution was allowed to incubate for
48 hours at 4°C. The evening prior to addition, secondary antibody was prepared as
previously described.

Following the 48 hour incubation, 100 μl of resuspended

secondary antibody was added to all tubes except the TC tubes. Tubes were mixed and
allowed to incubate an additional 24 hours. The reaction was stopped by adding 2 ml of
cold PBS buffer to all tubes except the TC tubes. Samples were then centrifuged at 2280
x g for 30 minutes at 4°C. Following centrifugation, the supernatant was poured off and
tubes were counted for radioactivity. Data were then analyzed using FOURFIT (Boyer
and Grotjan, University of South Dakota School of Medicine, Vermillion, SD), a four
parameter logistic curve fitting program, to determine FSH levels.
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RNA Extraction
Tissue was removed from the RNAlater solution and RNA extracted using the
RNeasy Midi Kit (Qiagen, Inc., Valencia, CA). Briefly, the anterior pituitary gland from
each animal was homogenized in a 50-ml conical tube containing 2 ml of Buffer RLT (10
μl β-mercaptoethanol per ml of Buffer RLT) using the Tissue Tearor homogenizer
(BioSpec Products, Inc., Bartlesville, OK). Buffer RLT inactivates RNases to ensure the
isolation of intact RNA species. Following homogenization, the material was transferred
to a clean 15-ml conical tube and centrifuged for 10 minutes at 4000 x g to produce an
upper fatty layer, supernatant and pellet. The supernatant was removed and transferred to
a clean 15-ml conical tube, 2 ml of 70% ethanol was added and the solution was mixed
well.

The mixture was then added to an RNeasy Midi Spin Column (Qiagen),

centrifuged for 5 minutes and the flow-through discarded. Next, 4 ml of Buffer RW1
was added to the column, and it was centrifuged for 5 minutes. An additional two washes
with 2.5 ml of Buffer RPE and 2 and 5 minute centrifugation steps followed. Finally,
RNA was eluted by adding 150 μl of RNase free water to the column and centrifuging for
5 minutes. The resulting flow-through was transferred to a clean 1.5-ml microcentrifuge
tube and stored at -80°C until needed. This method of extraction effectively isolates
RNA species greater than 200 nucleotides while removing other contaminants.
Quality and integrity of extracted RNA was determined by Dr. Yuannan Xia
(Genomics Core Research Facility, UNL) using an Agilent 2100 bioanalyzer (Agilent
Technologies, Inc., Palo Alto, CA; Fig. 3.2). All samples used in this study met
standards of integrity as determined by electropherogram and gel-like image results. A
representative image for each group is displayed in Fig. 3.3. Total RNA quantity was

A

B

28s

18s
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Figure 3.2. Examples of total RNA quality as determined using an Agilent 2100
bioanalyzer. Total RNA integrity was analyzed for each sample. Determination of
quality was made by analysis of the electropherogram and gel-like image results. Panel
A indicates intact total RNA suitable for use in further assays. Panel B represents
partially degraded total RNA and should be discarded.

28s
28s
28s

18s

18s

18s
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A

B

C

Figure 3.3. Representative electropherogram and gel-like image of total RNA from
pituitaries of Index (A), Meishan (B) and Control (C) line gilts using the Agilent 2100
bioanalyzer to determine RNA quality and integrity.
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determined using the RiboGreen RNA Quantitation Kit (Molecular Probes, Eugene, OR)
and a Wallac Victor2 microplate reader (Perkin Elmer, Boston, MA).

Reverse Transcription
Total RNA from each sample was treated with DNase to remove any
contaminating genomic DNA. Four microliters of RNA, 2 μl of RQ1 RNase free DNase
buffer (Promega, Madison, WI) and 4 U of RQ1 RNase free DNase (Promega) were
added to a 0.2-μl PCR tube. The mixture was incubated at 37°C for 30 minutes and
inactivated by the addition of 1 μl of RQ1 RNase free DNase Stop Solution (Promega)
for 10 minutes at 65°C. Total RNA was then quantified using the RiboGreen RNA
Quantitation Kit as per the manufacturer’s protocol (Molecular Probes).

Reverse

transcription (RT) of mRNA was performed using the TaqMan® Reverse Transcription
Reagents Kit (Applied Biosystems, Foster City, CA). In a 0.2-μl PCR tube, 1X RT
Buffer, 5.5 μM MgCl2, 500 μM dNTP mixture, 2.5 μM random hexamers, 0.4 U RNase
inhibitor, 3.125 U MultiScribe RT, 150 ng of RNA as calculated from the RiboGreen
quantitation, and RNase free water were added for a 20 μl total reaction volume. A
mastermix of the RT reagents was prepared and added to each RNA sample. Tubes were
mixed and incubated at 25°C for 10 minutes to maximize random hexamer binding to
RNA. This was followed by a 60 minute incubation at 37°C and an inactivation step of
95°C for 5 minutes.

cDNA Quantification
Upon completion of RT, each cDNA sample was quantified using the OliGreen
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ssDNAQuantitation Kit (Molecular Probes) as per manufacturer’s instructions. This
allowed dilution to an equal cDNA concentration among samples for subsequent
quantitative real-time PCR assays. It also verified the presence of cDNA in the sample as
OliGreen is more sensitive for measuring single stranded DNA species at low
concentrations than conventional absorbance methods (Molecular Probes, 2001).

Quantitative Real-Time PCR
Quantitative real-time PCR was performed using TaqMan probes (Applied
Biosystems Custom Oligo Synthesis Service, Foster City, CA) and primer sets
(Integrated DNA Technologies, Coralville, IA) designed and optimized for the GnRHR,
α-, LHβ- and FSHβ-subunits, and eukaryotic 18s rRNA (18s; Applied Biosystems) genes
(Table 3.5).
Each reaction was carried out in a 25 μl volume containing 1X Universal PCR
Master Mix without Amperase UNG, appropriate amounts of primers and probes (as
determined by optimization), 1X eukaryotic 18s rRNA mix and 2.5 ng cDNA, then
brought to volume with nuclease free water. Reactions were amplified in 96-well optical
grade PCR plates with optical adhesive strips (Axygen Scientific, Inc., Union City, CA)
in the ABI Prism 7700 Sequence Detection System (Applied Biosystems). Real-time
PCR cycling conditions were an initial incubation at 95°C for 10 minutes followed by 50
cycles of denaturing at 95°C for 15 seconds and annealing and elongation at 60°C for 60
seconds. Primer and probe sequences were designed using Primer Express Version 1.5
software (Applied Biosystems) and the GenBank sequence for the porcine GnRHR
(accession #L29342), α-subunit (accession #NM 214446), FSHβ-subunit (accession #NM
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213875) and LHβ-subunit (accession #NM 214080) genes.

Primer and probe

combinations for 18s were supplied by the manufacturer in the eukaryotic 18s rRNA Kit
(Applied Biosystems, Foster City, CA). Specificity of the amplicon was determined by
sequence analysis (Genetics Core Research Facility, UNL). Target gene (GnRHR, α-,
FSHβ- and LHβ-subunits) probes were synthesized by Applied Biosystems with the
reporter, 6-carboxyfluorescein (6-FAMTM), attached to the 5' end and quenching minor
groove binder (MGB) linked to the 3' end. The eukaryotic 18s rRNA control reagent
(Applied Biosystems) with VIC® reporter dye was used as an endogenous control gene to
adjust for sample loading differences. The 6-FAMTM reporter dye is distinguishable from
VIC® as a result of their different maximum emission wavelengths.

Appropriate

threshold values were set for each reaction, within the range of exponentially increasing
fluorescence, at a point of significance above baseline fluorescence.

The threshold

reflects a point during amplification where exponential amplification is occurring that
maximizes the precision of replicates as well as the sensitivity of the assay (Fig. 3.4).
Optimal primer and probe concentrations for GnRHR, α-, FSHβ- and LHβsubunits were determined. To determine optimal forward and reverse primer
concentrations, the probe concentration was held at 200 nM while primer combinations
of 100, 300, 600, and 900 nM were tested. The primer concentrations that had the
highest ΔRn value (the reporter signal normalized to the passive reference, ROX, for a
given reaction) were selected for each gene. These primer concentrations were then used
to determine optimal probe concentrations of 100, 200 or 300 nM. Optimal probe
concentration was determined in a similar manner to the primers. Optimal reaction
conditions for GnRHR were achieved with 600 nM forward and reverse primer and 200
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Figure 3.4. Setting of threshold in real-time PCR analysis. From
www.appliedbiosystems.com.
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nM probe. Concentrations of 100 nM forward and reverse primer and 200 nM probe
were determined to be optimal for α-, FSHβ- and LHβ-subunits. The 18s rRNA is
designed to be primer limiting to facilitate duplex reactions and was used according to
manufacturer’s recommendations (Applied Biosystems).
The linear dynamic range of GnRHR, α-, FSHβ- and LHβ-subunits, as well as 18s
was determined (Fig 3.5) and the relative efficiency of the genes of interest (GnRHR, α-,
FSHβ- and LHβ-subunits) to 18s was demonstrated (Fig 3.6). In order to make accurate
comparisons between samples, the efficiency of the target gene must be similar to that of
the endogenous control regardless of starting template amounts and expression levels. To
show this, serial dilutions of cDNA representative of each gene were run in triplicate
using optimized primer and probe concentrations. The average CT for each dilution was
plotted against the log of the input cDNA amount to ensure linearity. To determine
relative efficiency, the difference between the CT of the genes of interest and the CT of
18s (ΔCT) was plotted against the log starting input of cDNA. A slope with a value of
< 0.1 is indicative that the efficiency between the two genes would be similar at all
dilutions (Applied Biosystems, 2001). If the relative efficiency between the two genes is
not equal, comparisons between the samples would not be reliable.

TaqMan Data Analysis
Following completion of the real-time PCR reaction for samples for each animal,
the baseline and threshold to determine CT were established. The CT represents the cycle
number at which the fluorescence generated passes the fixed threshold and reflects a
point where a significant number of amplicons have accumulated to produce a signal
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Figure 3.5. Linear dynamic range and efficiency of real-time PCR assays. Dilutions of
cDNA were assayed to determine the linearity and efficiency of each assay. The average
CT value for each dilution was plotted against the log of the input cDNA amount. A slope
of -3.3 represents 100% PCR efficiency and should be no less than -3.6 (90%).
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Figure 3.5 continued.
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Figure 3.6. Relative efficiency of real-time PCR assays for each gene of interest
compared to eukaryotic 18s rRNA. Dilutions of cDNA were assayed for both the gene of
interest and 18s rRNA. The average ΔCT was plotted against the log input amount of
cDNA for each dilution point. A slope with an absolute value of < 0.1 indicates equal
PCR efficiencies and validates use of the ΔΔCT method of analysis.
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above that of the baseline. Fewer cycles to reach the threshold represent a greater amount
of gene expression whereas an increased number of cycles represent lower levels of
expression. The comparative CT method was used to evaluate data obtained from the
duplex reactions (Applied Biosystems, 2001). This method expresses data relative to a
calibrator sample. The ΔCT for GnRHR and α-, FSHβ- and LHβ-subunits compared to
18s was calculated to account for the amount of template added to each reaction. Then,
the ΔCT for an arbitrary calibrator was subtracted from each sample ΔCT (ΔΔCT). The
final value is expressed as 2-ΔΔCT. The data were also analyzed using the normalization
procedure. This method incorporates a reference gene that is expressed at the same level
in the tissue regardless of treatment. Using this analysis, the CT for each of the target
genes is divided by the CT for 18s to correct for template starting amounts.

GeneChip® Porcine Genome Array
Total RNA was assayed for gene expression using the Affymetrix GeneChip®
Porcine Genome Array (Affymetrix Inc., Santa Clara, CA). The assay was performed in
the Genomics Core Research Facility at the University of Nebraska-Lincoln. Briefly,
total RNA from the extraction described previously was pooled within breed x treatment
groups (n = 5 to 6 gilts per group) and RNA was precipitated by adding 0.3 M sodium
acetate followed by 1 volume of isopropanol. The solution was mixed and incubated at 20°C for one hour at which time it was centrifuged at 12,000 x g for 30 minutes at 4°C.
Following centrifugation, the supernatant was removed and the resulting pellet was
washed with 70% ethanol. The ethanol was removed and the pellet was allowed to dry.
The RNA pellet was then resuspended in 100 μl RNase free water. To this, 350 μl of
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Buffer RLT (Qiagen, Inc.) was added followed by 250 μl of 100% ethanol. After mixing,
the solution was applied to an RNeasy Mini column placed in a 2-ml collection tube and
centrifuged at 8,000 x g for 15 seconds. The RNeasy Mini column was then transferred
to a new 2-ml collection tube. To the column, 500 μl of Buffer RPE was added and it
was centrifuged as described above. The flow-through was discarded and an additional
500 μl of Buffer RPE was added to the column. This was followed by centrifugation at
8,000 x g for 2 minutes. The RNeasy Mini column was then placed in a fresh 1.5-ml tube
and 35 μl of RNase free water was added to the column followed by centrifugation at
8,000 x g for 1 minute. The RNA was quantified using RiboGreen, as previously
mentioned, and diluted to a concentration of 2 μg/μl and delivered to the Genomics Core
Research Facility (UNL). Samples were analyzed for quality and integrity using an
Agilent 2100 bioanalyzer (Agilent Technologies, Inc.).
The Affymetrix GeneChip® System uses arrays fabricated by direct synthesis of
oligonucleotide probes on glass slides using photolithographic technology. Hybridization
to the chip is DNA:RNA. Antisense copy RNA (cRNA), made from double stranded
cDNA that was derived from the mRNA samples, was transcribed in vitro using T7 RNA
polymerase in the presence of biotinylated CTP and UTP. The hybridized probe array
was stained with streptavidin phycoerythrin conjugate and scanned by the GeneChip®
Scanner 3000 (Affymetrix, Inc.). The amount of light emitted at 570 nm is proportional
to the bound target at each location on the probe array. Samples from each breed x
treatment group (n = 6) were hybridized on separate chips and then compared after
analysis. Analysis of image data was achieved using GeneChip® Operating Software
(Version 1.2; Affymetrix, Inc.). Each pooled sample was run in duplicate. Normalized
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data from the GeneChip® Operating Software package was analyzed using GeneSifter
(VizX Labs LLC, Seattle, WA; http://www.genesifter.net). Differential expression of
genes was determined by averaging duplicate arrays and running a pair-wise analysis.
Statistical significance was determined by Student’s t test and genes with differences (P <
0.05) were included in the analysis.

Statistical Evaluation
Statistical evaluation was conducted using the Statistical Analysis System (SAS,
2001). Values for LH and FSH were analyzed using the Proc GLM procedure. The LH
means were logarithmically transformed due to nonnormality, analyzed for significance,
and back-transformed to the original scale (Bland and Altman, 1996). Least-squares
means for both LH and FSH were compared using least significant differences. The
statistical model used was as follows: Yijk = μ + Li + Tj + (LT)ij + εijk, where Y is the
response variable (LH), μ is the overall mean of the response variable, L is the line effect
(Control, Index, Meishan), T is the treatment effect (SB-75 or vehicle), and ε is the
residual. The expression levels of GnRHR and α-, FSHβ- and LHβ-subunit genes were
analyzed using the Proc GLM procedure. The normalized, as well as 2-ΔΔCT, amount of
mRNA for each group was analyzed. Least squares means for amounts of GnRHR, αsubunit and LHβ-subunit gene expression were logarithmically transformed due to
nonnormality, analyzed for significance, back-transformed to the original scale (Bland
and Altman, 1996), and compared using least significant differences. Least squares
means for FSHβ-subunit expression levels using the 2-ΔΔCT method were square root
transformed due to nonnormality, analyzed, back-transformed to the original scale (Bland
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and Altman, 1996), and compared using least significant differences. Least squares
means for the 2-ΔΔCT method are expressed as relative expression over the arbitrary
calibrator. Means for normalized data are expressed as expression relative to 18s rRNA.
The statistical model used was as follows: Yijk = μ + Li + Tj + (LT)ij + εijk, where Y is
the response variable (normalized or 2-ΔΔCT expression), μ is the overall mean of the
response variable, L is the line effect (Control, Index, Meishan), T is the treatment effect
(SB-75 or vehicle), and ε is the residual.
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CHAPTER IV

Responsiveness of GnRH Receptor and Gonadotropin Subunit Genes Following
Treatment with the GnRH Antagonist, SB-75, in Lines of Swine Divergent for
Ovulation Rate
Abstract
The interaction of GnRH with its receptor represents a crucial point for control of
reproductive function, regulating expression of genes encoding the gonadotropin subunits
and GnRH receptor (GnRHR) itself.

In addition to its physiological relevance, the

porcine GnRHR gene is a positional candidate for genes that influence reproductive
efficiency because it is located in a similar chromosomal region to a quantitative trait
locus (QTL) for ovulation rate (OR). Evaluation of gonadotropic gene expression in lines
of swine divergent for ovulation rate may provide insight into the phenomena of
increased litter size. Chinese Meishan (OR = 14.5), a white crossbred line selected for
several generations based on an index of OR and embryonic survival (Index; OR = 17.8),
and a control line (Control; OR = 13.2) were evaluated in this study. Following three
(Index and Control) or six (Meishan) successive estrous cycles, gilts were ovariectomized
to remove endogenous steroid hormones. After a 21 d recovery period, gilts from each
line were treated with either a specific GnRH antagonist (SB-75; 10 μg/kg bw) or 0.9%
saline at 60, 36 and 12 h prior to sacrifice. Blood samples were collected prior to the first
treatment and at sacrifice before anterior pituitary collection. Serum LH and FSH levels
were determined by RIA, and RNA was extracted from anterior pituitary tissue. In all
breeds, LH was reduced to basal levels by SB-75 treatment, confirming the efficacy of
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SB-75. In contrast, levels of FSH decreased only in Control gilts following treatment
with SB-75.

Levels of GnRHR and gonadotropin subunit gene expression were

measured by quantitative real-time PCR. Basal expression of the GnRHR gene was
higher in Meishan compared to Control pituitaries, but Index GnRHR mRNA levels were
similar to both lines. Levels of pituitary GnRHR gene expression were reduced in
Control and Index, but not Meishan females following treatment. Initial amounts of
glycoprotein α-subunit mRNA were highest in Control and Index compared to Meishan
anterior pituitary tissue. Further, α-subunit expression decreased following treatment in
pituitaries from the Control and Index lines only.

Prior to SB-75 treatment, pituitary

FSHβ-subunit mRNA levels were higher in Control and Index compared to Meishan gilts.
After treatment, FSHβ-subunit mRNA levels decreased in Control and Index but not in
Meishan gilts. Expression of the LHβ-subunit gene was highest in Control, intermediate
in Index and lowest in Meishan pituitaries; however, amounts of LHβ-subunit mRNA
decreased in Control and Index following treatment and remained unchanged in Meishan.
Thus, GnRHR and gonadotropin subunit gene expression patterns in lines of swine
divergent for OR suggest differential mechanisms for GnRH regulation of gonadotrope
function.

Introduction
Prolificacy of females is an important measure of productivity in the swine
industry, representing a trait of dramatic economic importance. Two major components
of litter size are uterine capacity and ovulation rate, a trait that differs significantly
between strains of swine. While uterine capacity is a key component to litter size, it is
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not easily quantified thus making selection for this trait difficult.

Ovulation rate,

however, can be improved in many ways including nutritional flushing and genetic
selection. However, there is very little known about the mechanisms behind increased
ovulation rate in swine.
Two principal components of ovulation rate, follicle recruitment and ovulation,
are stimulated by the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing
hormone (LH), respectively. The pulsatile release of GnRH from the hypothalamus and
its subsequent binding to specific high-affinity receptors on gonadotrope cells within the
anterior pituitary gland not only stimulates, but is also obligatory to the synthesis and
secretion of FSH and LH (Clayton and Catt, 1981; Clarke et al., 1983).

The

gonadotropins are heterodimeric glycoproteins, each sharing a common α-subunit;
however, it is the individual β-subunits that give FSH and LH biological specificity. The
interaction of GnRH with the GnRHR stimulates the expression of at least four genes
including the α-subunit, LHβ- and FSHβ-subunits, and the GnRHR itself. In addition to
the amount of GnRH available, gonadotropin secretion is dependent on the number of
GnRHRs available, establishing their importance in normal reproductive function (Wise
et al., 1984). Unique to the pig, the GnRHR gene lies in a similar chromosomal region as
a QTL for OR (Rohrer, 1999).

Therefore, the GnRHR gene represents both a

physiological and positional candidate for genes determining ovulation rate in swine.
Pulse amplitude and pattern of GnRH stimulation differentially regulate
expression of the gonadotropin subunit genes (α-, FSHβ and LHβ-subunits; Haisenleder
et al., 1991). Also, gonadotropin subunit mRNA is differentially regulated following
ovariectomy (Burger et al., 2001). The FSHβ-subunit gene is regulated by GnRH to a
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lesser extent than the α- and LHβ-subunits, and is positively regulated by activin (Weiss
et al., 1992). However, estradiol-17β (Guthrie and Bolt, 1985) and inhibin (Braden et al.,
1990) have negative actions on expression of the FSHβ-subunit gene. Estradiol-17β also
functions to prime GnRHR numbers (Gregg et al., 1990) and preferentially stimulates
transcription of the LHβ-subunit gene in anterior pituitary cell cultures (Shupnik et al.,
1989). Differential regulation of the gonadotropin subunits creates the potential for
differential secretion of the respective gonadotropins during the estrous cycle.
Follicular development is dependent on the actions of FSH and LH at the level of
the ovary (Lucy et al., 2001). The production of FSH and LH in response to GnRH
stimulation is correlated with the number of GnRHRs present on the gonadotrope cell
surface within the anterior pituitary gland (Wise et al., 1984). Sensitivity to GnRH and
other hormones, or number of GnRHRs present on the anterior pituitary gland may
stimulate higher levels of gonadotropin production and thus, increase ovulation rate. A
study by Knox et al. (2003) indicated that concentrations of both FSH and LH were
elevated in lines of swine with increased OR (17 to 26 CL) when compared to control
lines (12 to 16 CL).
The genomic sequence for the porcine GnRHR gene was reported by Jiang and
associates (2001). Sequence analysis revealed several polymorphisms within the coding
sequence for the GnRHR gene between Chinese Meishan and white crossbred pigs,
resulting in at least three amino acid substitutions. The Chinese Meishan breed of swine
is one of the most prolific breeds, producing four to five more piglets per litter than
occidental lines, due, in part, to increased OR (White et al., 1993; Christenson et al.,
1993). Consistent with this model, scientists at the University of Nebraska – Lincoln
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(UNL) have developed a line of pigs that were selected for greater than 14 generations
based on an index of OR and embryonic survival at 50 d of gestation. This line of white
crossbred pigs ovulates seven more eggs each cycle (Generation 10; Johnson et al., 1999)
and produces 2.53 more live born piglets per litter than control animals (Control;
Generation 19; Petry and Johnson, 2004). Using these genetic models, the objective of
this study was to examine expression patterns of the GnRHR and gonadotropin subunit
genes in lines of swine divergent for OR.

Materials and Methods
Animals. All animal procedures used in this study were approved by the UNL
Institutional Animal Care and Use Committee. White crossbred Index and Control line
gilts (Generation 23) were transported to the UNL Animal Science Building from the
University of Nebraska Agricultural Research and Development Center (ARDC) Swine
Unit. Gilts of the Meishan breed were transported to the Animal Science Building from
the United States Department of Agriculture, Roman L. Hruska U.S. Meat Animal
Research Center in Clay Center, Nebraska. Gilts were housed in pens with a minimum of
8 square feet of floor space, 4 pounds of feed per day and water available ad libitum.
Gilts of the Index and Control lines were detected for estrus beginning at 155 days of age
whereas estrous detection began at 95 days of age for Meishan females.

Treatments.

Upon completion of the third (Index and Control) or sixth

(Meishan) estrus, ten gilts from the Index and Control lines and 12 Meishan gilts were
ovariectomized during the luteal phase (Day 5 to 15 of the estrous cycle). A preliminary
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study in our laboratory and previous reports (Christenson et al., 1993; Hunter et al., 1993)
indicated that Meishan gilts do not exhibit increased ovulation rates following three
estrous cycles when compared to gilts occidental breeds. Thus, Meishan females were
allowed an additional three estrous cycles to achieve OR at a level above that of control
gilts. Twenty-one days after ovariectomy, gilts from each line were randomly assigned to
treatment groups and received an injection of either the specific GnRH antagonist, SB-75
(10 μg biologically active compound per kg of body weight; UNL Protein Core Facility),
or vehicle (0.9% saline) at 60, 36 and 12 hours prior to sacrifice (Fig. 3.1).

Serum and Tissue Collection.

Blood samples were collected via jugular

venopuncture prior to ovariectomy and the first SB-75 injection. Gilts from the Index,
Control and Meishan lines were transported to the UNL abattoir the morning of sacrifice.
Animals were rendered unconscious by electrical stunning followed by exsanguination.
At this time, a blood sample and the head were collected. The pituitary gland was
excised and transferred to a sterile Petri dish using RNase free utensils. The anterior and
posterior pituitaries were separated and the anterior pituitary was divided into quarters.
One quarter was placed in a sterile 2-ml cryovial and snap frozen in liquid nitrogen. The
remaining three quarters of the pituitary (approximately 65 mg of tissue per quarter) were
placed in RNAlater (Ambion, Inc., Austin, TX) and kept on ice for later RNA extraction.

Radioimmunoassay. Concentrations of serum LH were determined using an
RIA validated in our laboratory. Iodination grade porcine LH (AFP11043B, A.F. Parlow,
National Hormone & Peptide Program, Harbor-UCLA Medical Center, Torrance,
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California) was iodinated using a “controlled” chloramine-T method (Proudman and
Wentworth, 1978) and then used to measure LH concentrations.

A standard curve

ranging from 0.03 – 5.0 ng/ml was used (prepared from AFP11043B). The porcine LH
antibody (AFP15103194Rb, A.F. Parlow) was used at a working dilution of 1:210,000.
Standards and samples were added to numbered glass tubes. Next, the porcine LH
antibody and iodinated LH were added and this mixture was allowed to incubate for 48
hours at 4°C. Second antibody [89% phosphate buffered saline-0.1% gel (PBS-gel),
10.5% donkey anti-rabbit gammaglobulin (dARGG), 0.5% normal rabbit serum (NRS)]
was then added, followed by an incubation of 24 hours at 4°C. One ml of PBS buffer
was added followed by centrifugation at 3200 x g for 45 minutes. Supernatant was
removed and pellets counted for radioactivity.
Serum FSH concentrations were determined using an RIA validated in our
laboratory.

Iodination grade porcine FSH (AFP10640B, A.F. Parlow) was used to

determine FSH concentrations. A standard curve ranging from 200 – 3200 ng/ml was
used (prepared from AFP10640B).

The porcine FSH antibody (AFP2062096, A.F.

Parlow) was used at a working dilution of 1:300,000. Standards and samples were added
to numbered glass tubes. Next, the porcine FSH antibody and iodinated FSH were added
and this mixture was allowed to incubate for 48 hours at 4°C. Second antibody (84.5%
PBS-0.1% gel, 15% dARGG, 0.5% NRS) was then added, followed by an incubation of
24 hours at 4°C. One ml of PBS buffer was added followed by centrifugation at 3200 x g
for 30 minutes. Supernatant was removed and pellets counted for radioactivity.
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RNA Extraction and Reverse Transcription. Tissue was removed from the
RNAlater solution and RNA extracted using the RNeasy Midi Kit as per manufacturer’s
instructions (Qiagen, Inc., Valencia, CA). Quality and integrity of extracted RNA was
determined at the Genomics Core Research Facility (UNL) using an Agilent 2100
bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA). Total RNA from each animal
was treated with DNase to remove any contaminating genomic DNA. Four μl of RNA, 2
μl of RQ1 RNase-free DNase buffer (Promega, Madison, WI) and 4 U of RQ1 RNasefree DNase (Promega) were added to a 0.2-ml PCR tube. The mixture was incubated at
37°C for 30 minutes and inactivated by the addition of 1 μl of RQ1 RNase-free DNase
Stop Solution (Promega) for 10 minutes at 65°C. Total RNA quantity was determined
using the RiboGreen RNA Quantitation Kit (Molecular Probes, Eugene, OR) and a
Wallac Victor2 microplate reader (Perkin Elmer, Boston, MA). Reverse transcription
(RT) of mRNA was performed using the TaqMan® Reverse Transcription Reagents Kit
(Applied Biosystems, Foster City, CA). In a 0.2-μl PCR tube, 1X RT Buffer, 5.5 μM
MgCl2, 500 μM dNTP mixture, 2.5 μM random hexamers, 0.4 U RNase inhibitor, 3.125
U MultiScribe RT, 150 ng of RNA (calculated from the RiboGreen quantitation), and
RNase-free water were added for a 20 μl total reaction volume. Tubes were mixed and
incubated at 25°C for 10 minutes, followed by 60 minute incubation at 37°C and an
inactivation step of 95°C for 5 minutes. The cDNA from each sample was quantified
using the OliGreen ssDNA Quantitation Kit (Molecular Probes) as per manufacturer’s
instructions.
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Quantitative Real-time PCR.

Primers (Table 3.4) were designed for the

GnRHR, α-, FSHβ- and LHβ-subunit genes according to GenBank sequences using
Primer Express (Version 1.5; Applied Biosystems). Real-time PCR was carried out using
an ABI Prism 7700 (Applied Biosystems) using gene-specific probes (Table 3.4) for the
detection of PCR products. The final 25 μl reaction contained 1X Universal PCR Master
Mix without Amperase UNG, 200 nM (α-, FSHβ- and LHβ-subunits) or 600 nM
(GnRHR) forward and reverse primer, 200 nM probe, 1X eukaryotic 18s rRNA mix and
2.5 ng cDNA, then brought to final volume with nuclease free water. Reactions were
amplified in 96-well optical grade PCR plates with optical adhesive strips (Axygen
Scientific, Inc., Union City, CA). Real-time PCR cycling conditions were an initial 95°C
incubation for 10 minutes followed by 50 cycles of denaturing at 95°C for 15 seconds
and annealing and elongation at 60°C for 60 seconds. Ribosomal 18s RNA was used as
an endogenous control for each sample, and the Ct value of each sample was normalized
to that of 18s rRNA.

Statistical Analysis. Statistical evaluation was conducted using the General
Linear Models procedure of the Statistical Analysis System (SAS, 2001). The LH means
were logarithmically transformed due to nonnormality, analyzed for significance and
back-transformed to the original scale (Bland and Altman, 1996) prior to analysis. Leastsquares means for LH and FSH were compared using least significant differences. Least
squares means for expression levels of GnRHR and α-, FSHβ- and LHβ-subunit genes
were logarithmically transformed due to nonnormality, analyzed for significance, backtransformed to the original scale (Bland and Altman, 1996), and compared using least
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significant differences. Means for normalized data are expressed as a ratio of the gene of
interest relative to 18s rRNA.

Results
Radioimmunoassay. Serum collected before and after ovariectomy and
following treatment at sacrifice was assayed for LH and FSH concentration. Levels of LH
in gilts prior to ovariectomy were similar between Control (1.25 ng/ml), Meishan (1.21
ng/ml), and Index (1.05 ng/ml) lines (P > 0.05). Serum LH levels increased significantly
following ovariectomy (P < 0.05) but did not differ between lines after ovariectomy (Fig.
4.1). Treatment with SB-75 caused a significant reduction in LH compared to gilts given
vehicle in all lines (P < 0.001; Fig. 4.2). The decrease in LH following treatment
indicated the ability of SB-75 to antagonize GnRH action at the GnRHR.
Levels of serum FSH were also similar between Control (432.89 ng/ml), Index
(408.56 ng/ml) and Meishan (382.85 ng/ml) gilts prior to ovariectomy, significantly
increasing following removal of ovaries (Figure 4.3). Post-ovariectomy levels of FSH
were higher in Control gilts compared to Index or Meishan females (P <0.05). Serum
FSH levels decreased in Control gilts (P < 0.01) and had a tendency to decline in Index
gilts following treatment with SB-75 (P < 0.10). Conversely to LH results, Meishan FSH
levels remained elevated following SB-75 treatment (Fig. 4.4).

Gene Expression. Anterior pituitary levels of GnRHR mRNA were highest in
Meishan, intermediate in Index, and lowest in Control line gilts when normalized to 18s
rRNA expression (Fig. 4.5). Treatment with SB-75 caused a reduction of GnRHR gene
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expression in the Index and Control lines (P < 0.05), but there was only a trend for a
decrease in GnRHR mRNA levels in Meishan gilts (P < 0.10). Analysis using the ΔΔCT
method was in agreement with normalization, however, Meishan and Index GnRHR
expression levels were similar (P > 0.05; Fig. 4.6).
In pituitaries from Meishan gilts, levels of α-subunit mRNA were lower than
those of Control and Index gilts. Following treatment with SB-75, a significant reduction
was observed in pituitary α-subunit gene expression of Control and Index lines (P <
0.0001). Similar to the GnRHR gene, levels of α-subunit mRNA in Meishan anterior
pituitaries were unchanged (Fig 4.7). Results using the ΔΔCT method confirmed the
normalized data (Fig 4.8).
As was observed with the α-subunit, levels of pituitary FSHβ-subunit gene
expression were lower in the Meishan compared to Control and Index lines. There was a
decrease in values for FSHβ-subunit mRNA in anterior pituitaries of both Control and
Index gilts receiving treatment with SB-75 (P < 0.0001); however there was no change in
FSHβ-subunit expression levels in Meishan gilts (Fig. 4.9). Pituitary expression of the
FSHβ-subunit in the Index line was intermediate compared to Control and Meishan gilts
(P < 0.05) using the ΔΔCT method to analyze real-time PCR data.

Similar to

normalization to 18s rRNA, FSHβ-subunit gene expression in pituitaries from the Index
and Control lines decreased with SB-75 treatment, but FSHβ-subunit mRNA levels in the
Meishan breed were unchanged (Fig. 4.10).
Anterior pituitary levels of LHβ-subunit mRNA were lower in Meishan than
Control gilts (P < 0.05), with Index gilts being intermediate, prior to treatment. A
decrease in LHβ mRNA levels was observed in pituitaries from Control and Index gilts
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treated with SB-75 (P < 0.0001). There was no significant decline in LHβ-subunit gene
expression in pituitaries of Meishan females (Fig. 4.11). Pituitary levels of LHβ-subunit
mRNA were similar to the normalized data in all untreated groups using the ΔΔCT
method (P > 0.05).

Similar to normalization, levels of LHβ-subunit mRNA were

decreased with SB-75 treatment in pituitaries from all lines but Meishan (Fig. 4.12).

95

3

LH (ng/ml)

2.5

**

**
*

2

**

**

**

Control
Index

1.5
1

**

**

**

Meishan

0.5
0
OVX
Pre-OVX

Pre Trt
Post-OVX

Untreated
Vehicle

SB-75

Figure 4.1. Changes in serum LH levels in Control, Index and Meishan gilts before (PreOVX) and after (Post-OVX) ovariectomy and following treatment with vehicle or the
GnRH antagonist, SB-75. Gilts were ovariectomized and treated with 0.9% saline or a
specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior to slaughter. Each bar
represents the least-squares mean ± SEM of 5-6 gilts. Bars with asterisks are different
than Pre-OVX and SB-75 treated groups (P < 0.05).
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Figure 4.2. Changes in serum LH levels in Control, Index and Meishan gilts following
treatment with vehicle or the GnRH antagonist, SB-75. Gilts were ovariectomized and
treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior
to slaughter. Each bar represents the least-squares mean ± SEM. Bars with different
letters are different (P < 0.001).
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Figure 4.3. Changes in serum FSH levels in Control, Index, and Meishan gilts before
(Pre-OVX) and after (Post-OVX) ovariectomy and following treatment with vehicle or
the GnRH antagonist, SB-75. Gilts were ovariectomized and treated with 0.9% saline or
a specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior to slaughter. Each bar
represents the least-squares mean ± SEM of 5-6 gilts. Bars with asterisks are different
than Pre-OVX (P < 0.05).

98

1100
1000

a

900

FSH (ng/ml)

800

b

700
600
500
400
300

n=5

n=5

n=5

n=5

n=6

n=6

200
100
0
SB-75
Line

Control

-

+

Control

-Index +
Index

Meishan

-

+

Meishan
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Figure 4.5. Normalized expression of the GnRHR gene in pituitaries of Control, Index
and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60,
36, and 12 h prior to slaughter. The anterior pituitary gland was collected and RNA
extracted. Using specific primers and probes, real-time PCR was performed to determine
levels of GnRHR mRNA. Normalized values are expressed as the CT measured for
GnRHR divided by the CT measured for 18s rRNA (± SEM). Bars with different letters
are different (P < 0.05).
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Figure 4.6. Relative expression of the GnRHR gene in Control, Index and Meishan gilts
treated with vehicle or the GnRH antagonist, SB-75. Gilts were ovariectomized and
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior
to slaughter. The anterior pituitary gland was collected and RNA extracted. Using
specific primers and probes, real-time PCR was performed to determine levels of GnRHR
mRNA. Analysis was carried out using the ΔΔCT method. Bars with different letters are
different (P < 0.05).
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and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60,
36, and 12 h prior to slaughter. The anterior pituitary gland was collected and RNA
extracted. Using specific primers and probes, real-time PCR was performed to determine
levels of α-subunit mRNA. Normalized values are expressed as the CT measured for the
α-subunit gene divided by the CT measured for 18s rRNA (± SEM). Bars with different
letters are different (P < 0.05).
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Figure 4.8. Relative expression of the α-subunit gene in Control, Index and Meishan gilts
treated with vehicle or the GnRH antagonist, SB-75. Gilts were ovariectomized and
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior
to slaughter. The anterior pituitary gland was collected and RNA extracted. Using
specific primers and probes, real-time PCR was performed to determine levels of αsubunit mRNA. Analysis was carried out using the ΔΔCT method. Bars with different
letters are different (P < 0.05).
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Figure 4.9. Normalized expression of the FSHβ-subunit gene in pituitaries of Control,
Index and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60,
36, and 12 h prior to slaughter. The anterior pituitary gland was collected and RNA
extracted. Using specific primers and probes, real-time PCR was performed to determine
levels of FSHβ-subunit mRNA. Normalized values are expressed as the CT measured for
the FSHβ-subunit gene divided by the CT measured for 18s rRNA (± SEM). Bars with
different letters are different (P < 0.05).
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Figure 4.10. Relative expression of the FSHβ-subunit gene in Control, Index and
Meishan gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were
ovariectomized and treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60,
36, and 12 h prior to slaughter. The anterior pituitary gland was collected and RNA
extracted. Using specific primers and probes, real-time PCR was performed to determine
levels of FSHβ-subunit mRNA. Analysis was carried out using the ΔΔCT method. Bars
with different letters are different (P < 0.05).
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Figure 4.11. Normalized expression of the LHβ-subunit gene in pituitaries of Control,
Index and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60,
36, and 12 h prior to slaughter. The anterior pituitary gland was collected and RNA
extracted. Using specific primers and probes, real-time PCR was performed to determine
levels of LHβ-subunit mRNA. Normalized values are expressed as the CT measured for
the LHβ-subunit gene divided by the CT measured for 18s rRNA (± SEM). Bars with
different letters are different (P < 0.05).
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Figure 4.12. Relative expression of the LHβ-subunit gene in Control, Index and Meishan
gilts treated with vehicle or the GnRH antagonist, SB-75. Gilts were ovariectomized and
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior
to slaughter. The anterior pituitary gland was collected and RNA extracted. Using
specific primers and probes, real-time PCR was performed to determine levels of LHβsubunit mRNA. Analysis was carried out using the ΔΔCT method. Bars with different
letters are different (P < 0.05).
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Discussion

Binding of GnRH to its receptor leads to the synthesis and release of the
gonadotropins, implicating the physiological role of the GnRHR in reproductive function.
Further, the GnRHR gene is located in a similar region of porcine chromosome 8 as a
QTL for OR (Rohrer 1999). Therefore, the GnRHR gene represents both a physiological
and positional candidate for genes influencing OR.

In addition, the gonadotropins

contribute to key components of OR, follicle recruitment (FSH) and ovulation (LH).
Recognizing the physiological importance of the GnRHR and gonadotropins in
determination of OR, we explored the response of genes encoding the GnRHR and
gonadotropin subunits to treatment with the GnRH antagonist, SB-75, in ovariectomized
females from lines of swine divergent for OR.
In the current study, there was no difference in levels of serum LH or FSH
between groups before or after ovariectomy. Accordingly, Tilton and associates (1994)
also reported no difference in the amount of serum FSH or LH between Meishan and
white crossbred gilts following ovariectomy. Others have reported similar LH or FSH
levels between white crossbred and Meishan sows prior to ovariectomy; however LH
levels were elevated in white crossbred over Meishan sows following ovariectomy (Wise
et al., 2001). In our experiment, the effectiveness of the GnRH antagonist, SB-75, was
established based on a decline in LH levels of ovariectomized gilts receiving treatment.
In contrast, whereas levels of serum FSH increased following ovariectomy in all lines, a
significant response to treatment with SB-75 was only observed in Control gilts. In a
previous study, a decrease in serum LH following treatment with SB-75, with only a
modest effect on FSH concentration, in Meishan and white crossbred sows was also
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observed (Wise et al., 2001). Others have also reported that treatment with SB-75 does
not affect FSH concentrations as strongly as LH levels, possibly due to differential
regulation of the gonadotropin β-subunits or the half-life of FSH (Reissmann et al.,
2000). Gonadotropin concentrations following treatment with SB-75 suggest that GnRH
stimulation of gonadotropes regulates production and secretion of FSH and LH in a
differential manner.
Tilton and colleagues (1994) reported that ovariectomized Large White gilts had
higher FSH and LH levels than Meishan gilts following GnRH treatment. Levels of FSH
and LH returned to baseline in 90 and 60 minutes, respectively, in Meishan females but
remained elevated in Large White females for at least 4 hours. In addition, when these
gilts were treated with porcine follicular fluid, a more substantial effect on FSH was
observed in the Large White than Meishan gilts. This suggests that Large White females
may have greater sensitivity to ovarian negative feedback than Meishan females (Hunter,
1993). Large White females may harbor a larger releasable pool of gonadotropins,
metabolize GnRH less effectively, or have greater pituitary sensitivity to GnRH than
Meishan females, which may explain the differential gonadotropin response to GnRH
(Tilton et al., 1994). However, another study indicated that Meishan sows demonstrated
a longer duration of declined FSH concentrations following treatment with SB-75
compared to white crossbred sows (Wise et al., 2001). There may also be differences in
the clearance rate or receptor binding properties of gonadotropins between Meishan and
white crossbred females (Wise et al., 2001).
In the current study, expression levels of GnRHR and the gonadotropin subunits
declined following treatment with SB-75 in Index and Control, but not Meishan gilts.
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This indicates that GnRH exerts differential effects on regulation of gonadotropin subunit
gene expression among lines of swine. Regulation of the gonadotropin subunits most
likely occurs at the level of the anterior pituitary (GnRHR) rather than the hypothalamus
(GnRH). Within the gonadotrope, GnRH possesses the ability to stimulate differential
expression of the GnRHR and gonadotropin subunit genes (Weiss et al., 1992a).
Frequency-dependent regulation of FSHβ- and LHβ-subunit promoter expression by
GnRH was observed in LβT2 cells and male rat primary pituitary cultures with FSHβand LHβ-subunits stimulated at low and high GnRH pulse frequencies, respectively
(Bedecarrats and Kaiser, 2003; Kaiser et al., 1997). Patterns of the gonadotropins in
serum followed that of their respective subunits; however, there was a greater LH:FSH
ratio with more frequent GnRH pulses. Interestingly, levels of GnRHR mRNA were
more closely correlated with those of the LHβ-subunits than the FSHβ-subunit (Kaiser et
al., 1997). Similar to Kaiser and associates (1997), we determined that anterior pituitary
levels of GnRHR and LHβ-subunit mRNA mimicked each other in all lines following
SB-75 treatment. Levels of the GnRHR and gonadotropin subunit genes were only
measured at one time-point and GnRH levels were not determined in our study, thus a
relationship between GnRH and expression levels of the genes studied could not be
determined. However, it is possible that pulsatility plays less of a role in regulation of
gonadotropic genes in Meishan females. This may lead to the differential expression
patterns observed compared to Index and Control gilts for the gonadotropin subunits and
GnRHR.
In addition to effects of GnRH pulse frequency, the concentration of GnRHRs on
the gonadotrope cell membrane may affect gonadotropin subunit gene expression. It is

110
possible that GnRH signaling cascades may differ at low compared to high GnRHR
numbers. The level of membrane bound GnRHR or differential G-protein activation of
second messenger systems may explain the differential regulation of FSHβ- and LHβsubunit expression by GnRH (Stanislaus et al., 1998).

In both somatomammotrope-

derived GH3 (Kaiser et al., 1995) and gonadotrope-derived LβT2 (Bedecarrats and Kaiser,
2003) cells, treatment with GnRH resulted in an increase in α- and LHβ-subunit gene
expression at increasingly greater concentrations of GnRHR, whereas expression of the
FSHβ-subunit gene was most favorable at lower concentrations. Therefore, control of the
FSHβ-subunit appears to be dependent on the concentration of GnRHR on the membrane
of gonadotrope cells.

Once bound, GnRHR may couple with different G-proteins

depending on receptor concentration. This may occur due to differential activation of
various α and βγ G-protein subunits (Kaiser et al., 1995).

Thus, while all three

gonadotropin subunits are stimulated by GnRH at low levels of GnRHR, the α- and LHβsubunits are expressed at a higher level with increasing GnRHR concentrations through
further activation of the same pathway and inhibition of the FSHβ-subunit, through a
completely different pathway.
While GnRHR numbers were not measured in the current study, it is possible that
the amount of GnRHRs present on gonadotropes of ovariectomized Meishan gilts is more
suitable for production of all gonadotropin subunits than receptor numbers in Index and
Control gilts. Consistent with this, levels of GnRHR mRNA were higher in Meishan than
Index and Control gilts following treatment with SB-75. It is also possible that without
normal feedback from the gonads, gonadotropes of ovariectomized Meishans are not
sensitive to treatment with a GnRH antagonist. Finally, it is possible that mRNA poly(A)
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tail lengthening in Meishan gilts occurs with not only the LHβ- and α-subunits, but also
FSHβ-subunit and GnRHR, thus increasing half-life and exhibiting no difference in
expression as was observed in the current study. The length of LHβ- and α-subunit
poly(A) tails increased following ovariectomy in the rat, as well as with GnRH pulses in
rat pituitary cultures, which may allow post-transcriptional control of gonadotropin
mRNA stability or translational efficiency (Weiss et al, 1992a).
Others have investigated gene expression in anterior pituitaries of the Index and
Control lines. Bertani and associates (2004) reported greater expression of the α-subunit
in pituitaries from the Control line compared to the Index line using differential display
PCR. In the same study, FSHβ-subunit gene expression was greater in pituitaries of
females from the Index line than anterior pituitary tissue of the Control line. It was
suggested that the observed increase in FSHβ-subunit expression was due to direct
selection for enhanced reproductive traits (Bertani et al., 2004). In our study, however,
pituitary expression levels of the α- and FSHβ-subunits for ovariectomized Control and
Index females were similar for both genes.

In our experiment, the gilts were

ovariectomized, removing ovarian feedback whereas intact animals were used in the
study by Bertani and associates (2004).

A number of ovarian hormones, such as

estradiol-17β and inhibin can influence expression of gonadotropin subunits and may
have affected mRNA levels of the α- and FSHβ-subunits in the intact sows as compared
to ovariectomized gilts. Further, the discrepancy between studies may be due to the age
of the animals as those used in the study by Bertani et al. (2004) were second parity sows
and those used in the current study were gilts. Bertani and associates also induced
luteolysis between Day 12 and 14 of the estrous cycle and collected pituitaries 2 and 4
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days later. This may provide an inaccurate characterization of the gonadotropin subunit
genes in an induced compared to normal follicular phase.
In summary, treatment of ovariectomized gilts with the GnRH antagonist, SB-75,
caused a reduction in serum levels of LH in all lines, but levels of FSH were reduced in
Control animals only. Expression of the GnRHR, α-, FSHβ- and LHβ-subunit genes was
reduced in pituitaries of Index and Control line gilts, but not the Meishan line following
SB-75 treatment.

This implies a differential mechanism in gene regulation and

production of gonadotropins between Meishan and white crossbred lines of gilts. Also,
post-treatment levels of anterior pituitary GnRHR and LHβ-subunit mRNA were
significantly higher in females of the Meishan line as compared to both Control and
Index lines, suggesting that basal expression levels of these genes are increased in
Meishan gilts. Identification of such a trait, or traits, which could be easily screened and
correlated with OR in young animals would be of great interest for selection purposes.
This would allow even greater responses if the correlated trait could be measured in both
male and female animals (Smith et al., 1983).

Further research needs to be conducted

to elucidate the mechanisms controlling the observed differences in regulation of GnRHR
and gonadotropin subunit gene expression between Meishan and white crossbred lines of
swine.
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CHAPTER V

Microarray Analysis of GnRH Responsive Gene Expression in Anterior Pituitary
Tissue of Swine Lines Divergent for Ovulation Rate

Abstract
A fundamental control point for reproductive function in mammals is the binding
of GnRH to its receptor, an interaction that leads to the production and release of the
gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Additionally, the porcine GnRHR gene is a positional candidate for genes that influence
reproductive efficiency because it is located in a similar chromosomal region to a
quantitative trait locus (QTL) for ovulation rate (OR). Analysis of GnRH responsive
gene expression within anterior pituitary tissue of swine lines divergent for OR may
provide insight into the mechanisms that control OR, and subsequently increased litter
size.

Chinese Meishan (OR = 14.5), a white crossbred line selected for several

generations based on an index of OR and embryonic survival (Index; OR = 17.8), and a
control line (Control; OR = 13.2) were evaluated in this study. Following three (Index
and Control) or six (Meishan) successive estrous cycles, gilts were ovariectomized to
remove endogenous steroid hormones. After a 21 d recovery period, gilts from each line
were treated with either a specific GnRH antagonist (SB-75) or 0.9% saline (vehicle) at
60, 36 and 12 h prior to sacrifice. The anterior pituitary was removed and total RNA
extracted and pooled from 5 or 6 animals for each breed x treatment group (n = 6).
Affymetrix GeneChip® Porcine Genome Arrays were run on each RNA pool in duplicate
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and gene expression analyzed. Treatment with the GnRH antagonist, SB-75, decreased
or increased expression of 30, 17 and 33 genes in Control, Index and Meishan gilts,
respectively, of which 14, 7 and 11 genes were expressed at greater than 2-fold over gilts
treated with vehicle. Twenty-three genes were down-regulated in Control gilts and 7
genes had increased expression levels compared to vehicle treated females. Expression
of 12 genes was decreased in the anterior pituitary glands of Index line gilts, whereas
only 5 genes were up-regulated following treatment with SB-75. Gene expression in
ovariectomized Meishan gilts was increased and decreased in 25 and 8 genes,
respectively. Of interest were two genes, a member of the peptidase M23/M37 family
and an unknown gene, which were decreased in the anterior pituitary tissue of all swine
lines.

Introduction
Reproductive efficiency is of great importance to pork production as even a small
increase in average litter size holds the potential to increase profitability. Although litter
size in the U.S. improved during the last 15 years, the national average of 8.9 pigs per
litter (USDA, 2004) remains sub-optimal. Litter size is influenced by many factors;
however, a primary determinant of litter size is OR. In addition, OR is a trait that differs
significantly between strains of swine.
Gonadotropin-releasing hormone is a key molecule underlying regulation of
reproductive function in mammals. Upon binding to specific, high-affinity receptors on
gonadotrope cells of the anterior pituitary gland, GnRH stimulates the synthesis and
secretion of LH and FSH – two hormones which are essential for normal reproductive
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function in both males and females (Clayton and Catt, 1981; Clarke et al., 1983; Mason et
al., 1986). In addition to changes in levels of GnRH secretion, changes in the number of
pituitary receptors for GnRH have been implicated as an important mechanism
underlying regulation of LH and FSH secretion.

Thus, regulation of gonadotropin

secretion is dependent not only on GnRH availability, but also on the number of GnRH
receptors and, consequently, the sensitivity of the pituitary gland to a given dose of
GnRH (Wise et al., 1984). Similarly, GnRH and several other hormones have been
shown to regulate GnRHR numbers in the anterior pituitary gland (Sealfon and Millar,
1995). This increase in GnRHR numbers by GnRH is, in part, due to transcriptional
regulation of the GnRHR gene, especially since changes in GnRHR numbers associated
with GnRH treatments are correlated with changes in steady-state levels of mRNA
(Kaiser et al., 1993; Turzillo et al., 1994; Bauer-Dantoin et al., 1995).

Thus, the

interaction between GnRH and its cognate pituitary receptor serves as a central point for
regulation of reproductive function.
From a physiological perspective, FSH and LH stimulate two principal
components of ovulation rate, follicle recruitment and ovulation, respectively. Also, in
contrast to the GnRHR gene from other species, the porcine GnRHR gene is located in
the same chromosomal region as a QTL for ovulation rate (Rohrer et al., 1999).
Therefore, the GnRHR gene represents both a physiological and positional candidate for
genes determining ovulation rate in pigs. Consistent with this, we have detected a
quantitative difference in GnRHR mRNA levels between lines of swine divergent for
ovulation rate (Chapter IV). Additionally, differences in promoter activity of the GnRHR
gene have been established between lines of swine divergent for OR (McDonald et al.,
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unpublished data). Therefore, it is important to identify potential downstream effectors
influenced by the interaction between GnRH and its receptor and their role in
determination of OR in swine.
Toward this end, we used three lines of pigs which differed in OR. Chinese
Meishan females are very prolific as they produce four to five more pigs per litter than
their occidental counterparts, due, in part, to an increased OR (Christenson et al., 1993;
White et al., 1993). Consistent with this model, researchers at the University of Nebraska
developed a line of swine (Index) based on a selection index of OR and embryonic
survival.

This line of swine ovulates seven more eggs each cycle (Generation 10;

Johnson et al., 1999) and produces 2.53 more live born piglets per litter than control
animals (Control; Generation 19; Petry and Johnson, 2004). Although OR has been
extensively studied (Bennet and Leymaster, 1989), the genetic mechanisms that
determine OR in the pig remain unknown. The recent introduction of the Affymetrix
GeneChip® Porcine Genome Array creates a platform to identify multiple genes that may
be regulated by GnRH in the anterior pituitary of these swine models for determination of
OR.

This is likely given that it has been established by microarray analysis in

gonadotrope-derived LβT2 cells that over 200 genes are regulated by GnRH (Kakar et al.,
2003).

In the current study, we examined gene expression in the porcine anterior

pituitary gland following treatment with or without a GnRH antagonist of ovariectomized
gilts from lines of swine divergent for OR.
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Materials and Methods
Animals
All animal procedures used in this study were approved by the UNL Institutional
Animal Care and Use Committee.

White crossbred Index and Control line gilts

(Generation 23) were transported to the UNL Animal Science Building from the
University of Nebraska Agricultural Research and Development Center (ARDC) Swine
Unit. Gilts of the Meishan breed were transported to the Animal Science Building from
the United States Department of Agriculture, Roman L. Hruska U.S. Meat Animal
Research Center in Clay Center, Nebraska. Gilts were housed in pens with a minimum of
8 square feet of floor space, 4 pounds of feed per day and water available ad libitum.
Gilts of the Index and Control lines were detected for estrus beginning at 155 days of age
whereas estrous detection began at 95 days of age for Meishan females.

Treatments
Upon completion of the third (Index and Control) or sixth (Meishan) estrus, ten
gilts from the Index and Control lines, and 12 Meishan gilts were ovariectomized during
the luteal phase (Day 5 through 15 of the estrous cycle). On the basis of a preliminary
study in our laboratory, and previous reports (Christenson et al., 1993; Hunter et al.,
1993), Meishan females were allowed an additional three estrous cycles to increase OR to
a level above control gilts as Meishan gilts do not exhibit an increased OR following
three estrous cycles when compared to gilts from occidental breeds. Twenty-one days
after ovariectomy, gilts from each line were randomly assigned to treatment groups and
received an injection of either the specific GnRH antagonist, SB-75, (10 μg of
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biologically active compound per kg of bodyweight; UNL Protein Core Facility), or
vehicle (0.9% saline) at 60, 36 and 12 hours prior to sacrifice.

Tissue Collection and RNA Extraction
Gilts from the Index, Control, and Meishan lines were transported to the UNL
abattoir the morning of sacrifice. Animals were rendered unconscious by electrical
stunning followed by exsanguination. The pituitary gland was excised and transferred to
a sterile Petri dish using RNase-free utensils. The anterior and posterior pituitaries were
separated and the anterior pituitary was divided into quarters (approximately 65 mg of
tissue each) and placed in RNAlater (Ambion, Inc., Austin, TX) on ice for later RNA
extraction. Tissue was removed from the RNAlater solution and RNA extracted using
the RNeasy Midi Kit as per manufacturer’s instructions (Qiagen, Inc., Valencia, CA).
Following extraction, total RNA was pooled within breed x treatment groups (n = 5 to 6
gilts per group) and precipitated by adding 0.3 M sodium acetate followed by 1 volume
of isopropanol. The solution was mixed and incubated at -20°C for one hour, at which
time it was centrifuged at 12,000 x g for 30 minutes at 4°C. Following centrifugation, the
supernatant was removed and the resulting pellet was washed with 70% ethanol. The
ethanol was removed and the pellet was allowed to dry. The RNA pellet was then
resuspended in 100 μl RNase-free water. To this, 350 μl of Buffer RLT (Qiagen, Inc.)
was added followed by 250 μl of 100% ethanol. After mixing, the solution was applied
to an RNeasy Mini column placed in a 2-ml collection tube and centrifuged at 8,000 x g
for 15 seconds. The RNeasy Mini column was then transferred to a new 2-ml collection
tube.

To the column, 500 μl of Buffer RPE was added and it was centrifuged as
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described above. The flow-through was discarded and an additional 500 μl of Buffer
RPE was added to the column. This was followed by centrifugation at 8,000 x g for 2
minutes. The RNeasy Mini column was then placed in a fresh 1.5-ml tube and 35 μl of
RNase-free water was added to the column followed by centrifugation at 8,000 x g for 1
minute.
Pooled RNA was quantified using RiboGreen (Molecular Probes), diluted to a
concentration of 2 μg/μl and delivered to the Genomics Core Research Facility (UNL).
Pooled samples were analyzed for quality and integrity using an Agilent 2100
bioanalyzer (Agilent Technologies, Inc.). The Affymetrix GeneChip® System uses arrays
fabricated by direct synthesis of oligonucleotide probes on glass slides using
photolithographic technology. Hybridization to the chip is DNA:RNA. Antisense copy
RNA (cRNA), made from double stranded cDNA that was derived from the mRNA
samples, was transcribed in vitro using T7 RNA polymerase in the presence of
biotinylated CTP and UTP. The hybridized probe array was stained with streptavidin
phycoerythrin conjugate and scanned by the GeneChip® Scanner 3000 (Affymetrix, Inc.).
The amount of light emitted at 570 nm is proportional to the bound target at each location
on the probe array. Pooled samples from each breed x treatment group (n = 6) were
hybridized on separate chips and then compared after analysis. Analysis of image data
was achieved using GeneChip® Operating Software (Version 1.2; Affymetrix, Inc.).
Each pooled sample was run in duplicate.

Normalized data from the GeneChip®

Operating Software package was analyzed using GeneSifter (VizX Labs LLC, Seattle,
WA; http://www.genesifter.net). Differential expression of genes was determined by
averaging duplicate arrays and running a pair-wise analysis. Statistical significance was
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determined by Student’s t test and genes with differences (P < 0.05) were included in the
analysis.

Results and Discussion
The interaction between GnRH and its receptor is of great interest because it
represents a central point for regulation of reproductive function. The binding of GnRH
to its receptor enables the synthesis and secretion of FSH and LH – key components to
determination of OR in pigs. Further, the binding of GnRH to GnRHR leads to upregulation of genes encoding the subunits that comprise the gonadotropins as well as the
GnRHR gene itself.

In addition, the GnRHR represents both a physiological and

positional candidate for genes that influence OR. Therefore, it is important to gain a
better understanding of GnRH responsive gene expression among lines of swine to
examine if differential mechanisms exist for determination of OR.
To determine the expression profile of GnRH responsive anterior pituitary genes
we used the Affymetrix GeneChip® Porcine Genome array which contains 23,937 probes
sets that examine 23,256 transcripts from 20,201 genes. Antisense copy RNA prepared
from the anterior pituitary gland of vehicle treated gilts was used for comparative
analysis. The signal intensity of the arrays for various housekeeping genes and ribosomal
RNA were used to normalize expression of the genes. Relative expression levels were
visualized by plotting the SB-75 vs. vehicle treated intensities (Fig. 5.1).
The expression analysis revealed 68 genes that were up- or down-regulated in the
anterior pituitary gland of ovariectomized gilts from all three lines following treatment
with the GnRH antagonist, SB-75 (Table 5.1). Of the 68 genes, 23 displayed differences
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Figure 5.1. Pituitary gene expression following treatment with the GnRH antagonist,
SB-75, in lines of swine divergent for ovulation rate. Data for two arrays from each
breed x treatment group are shown as a scatter plot comparing expression of SB-75 vs.
vehicle treated (A) Control, (B) Index and (C) Meishan gilts.
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in pituitary expression levels following SB-75 treatment of 2-fold or more, and five were
expressed at greater than 4-fold compared to vehicle. Within pituitaries from Control
gilts there were 23 down-regulated genes and 7 up-regulated genes compared to those of
vehicle treated females. Expression of 12 genes was decreased in the Index line, whereas
only five genes were increased following treatment with SB-75. Gene expression in
ovariectomized Meishan gilts was down- and up-regulated for 8 and 25 genes,
respectively, after SB-75 treatment. Pituitary expression of two genes were decreased in
all lines, five genes were either decreased or increased in Control and Meishan, two genes
were decreased in Control and Index, and one gene was decreased in Index and Meishan
following exposure to the GnRH antagonist.
Analysis using microarray technology has revealed multiple genes that are
responsive to GnRH in the anterior pituitary glands of swine lines divergent for OR.
However, the identity of many of the genes remains unknown. For example, one of the
two genes that are down-regulated by SB-75 treatment in all three lines of swine has an
unknown identity. While expression of the unknown gene is down-regulated between
2.0- and 2.5-fold, it is the other gene, a homologue to the peptidase M23/M37 family, that
is the most interesting as expression levels decreased 7.0-, 4.3- and 3.2-fold in pituitaries
of Control, Index and Meishan gilts, respectively, after treatment with SB-75 (Table 5.2).
Also of interest are genes that are up- or down-regulated by the GnRH antagonist
in two of the three lines of pigs. Expression of genes encoding neuronal pentraxin II
(NP2), very low density lipoprotein receptor, and phospholipase C, gamma 2 (PLCγ2) are
decreased whereas DNA-damage-inducible transcript 4-like (DDIT4L) and an unknown
gene are up-regulated in pituitaries of SB-75 vs. vehicle treated Control and Meishan gilts.
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Control and Index females share a down-regulation of Complement 4 and the
hypothetical protein SAG0245 after SB-75 treatment, whereas Index and Meishan gilts
have decreased expression levels of the gene encoding V-ATPase C2 subunit in common
(Table 5.2).
Neuronal pentraxin II is a member of the pentraxin family of proteins which are
capable of forming pentameric complexes (Kao et al., 2003). Members of the pentraxin
family, including NP2, are involved in neuronal function (Garlanda et al., 2005). It has
been suggested that NP2 may function to remove degraded synaptic material during
formation and remodeling of synapses (Dodds et al., 1997).

Additionally, NP2 is

implicated in synaptic plasticity in the vestibular system, participating in adjustments in
synaptic efficacy or connectivity (Reti et al., 2002). Since GnRH is released from
hypothalamic neurons and travels to its receptors on gonadotropes in the anterior pituitary
gland, it is unclear what role NP2 may have in the anterior pituitary gland in the lines of
swine studied.
Phospholipase C-gamma 2 generates inositol triphosphate and diacylglycerol
following activation of tyrosine kinase receptors, but at a much slower rate than G
protein-coupled receptors (Berridge, 1993). Additionally, it has been suggested that
PLCγ2 is required for agonist-induced activation of calcium influx into the cell (Patterson
et al., 2002).

While PLCγ2 is probably affected indirectly from GnRH antagonist

treatment, it may offer an alternative means of calcium intake following GnRH
stimulation.
Another gene of particular interest is early growth response protein 1 (Egr-1)
which was down-regulated in Control females following SB-75 treatment. Early growth
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TABLE 5.2. FOLD-CHANGES IN PITUITARY GENE EXPRESSION IN LINES OF
SWINE DIVERGENT FOR OVULATION RATE DETERMINED BY AFFYMETRIX
GENECHIP® PORCINE GENOME ARRAY
GenBank
Accession
Number

TIGR Accession
Number

AW415941

TC228784

BQ601267

BX666127

CF365775

CN166587

BI182553

CN031558

CF366280

BQ602610

BI404208

TC225079

TC214846

TC204812

TC227308

----------

----------

TC199890

TC209620

TC219862

Description

homologue to
(Q8G137)
Peptidase
M23/M37 family

?

similar to
neuronal
pentraxin II

homologue to
very low density
lipoprotein
receptor

homologue to
phospholipase
C, gamma 2

similar to DNAdamageinducible
transcript 4-like

Fold Change

Control

-7.03

Index

-4.29

Meishan

-3.20

Control

-2.55

Index

-2.49

Meishan

-2.03

Control

-6.01

Meishan

-3.63

Control

-2.67

Meishan

-2.10

Control

-1.51

Meishan

-1.64

Control

+1.94

Meishan

+2.13

Control

+2.18

Meishan

+2.34

Control

-3.44

Index

-2.09

?

Complement 4

Control
Similar to
hypothetical
protein SAG0245 Index

homologue to
V-ATPase C2
subunit

-1.70
-2.01

Index

-3.08

Meishan

-2.73
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response protein 1 has been implicated in the transcriptional regulation of the rat α- and
LHβ-subunit genes (Gajewska and Kochman, 2001; Yoshino et al., 2002). The LHβsubunit contains an Egr-1 binding site that is part of a tripartite GnRH responsive element
also comprised of a steroidogenic factor 1 (SF-1) and specificity protein 1 (Sp-1) site
(Gajewska and Kochman, 2001). In addition, it was determined that the rat LHβ-subunit
promoter contains two overlapping EGR-1 consensus sequences between -171 and -137
bp of proximal promoter to which Egr-1 binds independently (Yoshino et al., 2002).
Further, it was demonstrated that GnRH rapidly stimulates expression of Egr-1 through
PKC/ERK activation of several serum response/Ets elements and a cAMP response
element (Duan et al., 2002).
In this study, we were interested in expression patterns of four genes in particular,
the GnRHR, α-subunit, FSHβ- and LHβ-subunits, because of their possible role in
determination of OR among swine lines (Table 5.3). Expression levels of the GnRHR
gene in all lines were numerically decreased, but not significantly, with the greatest
decline in Index (1.42-fold) and Control (1.33-fold) gilts following SB-75 treatment. No
change in gene expression for the α-subunit and LHβ-subunit as determined by
microarray analysis was observed among Control, Index or Meishan females treated with
the GnRH antagonist compared to vehicle. This was also true for expression patterns of
the FSHβ-subunit gene in Control and Meishan gilts, whereas Index females (1.14-fold)
had a non-significant numerical increase. This is in contrast to real-time PCR data in
which levels of the GnRHR, α-subunit, FSHβ- and LHβ-subunit mRNA were decreased
by SB-75 treatment in Control and Index, but not Meishan females (Chapter IV). The
discrepancy between microarray and real-time PCR measurement of gene expression has
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TABLE 5.3. FOLD-CHANGES IN PITUITARY GNRHR, Α-SUBUNIT, FSHΒ- AND
LHΒ-SUBUNIT GENE EXPRESSION IN LINES OF SWINE DIVERGENT FOR
OVULATION RATE DETERMINED BY AFFYMETRIX GENECHIP® PORCINE
GENOME ARRAY
Fold-decrease compared to Vehicle

Gene Name
GnRHR
α-subunit
FSHβ-subunit
LHβ-subunit

Control
1.33
1.02
1.06
1.02

Index
1.42
+1.01
1.14
+1.08

Meishan
1.17
+1.00
+1.04
+1.07
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been observed in other studies (Wurmbach et al., 2001).
Expression analysis of anterior pituitary glands from ovariectomized gilts treated
with the GnRH antagonist, SB-75, or vehicle provides insight into the regulation of
several GnRH responsive genes.

Results of the array identified several known and

unknown GnRH responsive genes that may be important in gonadotropin production,
such as Egr-1. Further research will continue to elucidate GnRH regulation of genes and
signaling pathways in the anterior pituitary gland of swine and their role in determination
of OR.

TABLE 5.1. PITUITARY EXPRESSION ANALYSIS OF LINES OF SWINE DIVERGENT FOR OVULATION RATE USING
THE AFFYMETRIX GENECHIP® PORCINE GENOME ARRAY
Accession No.
GenBank

Affymetrix Probe

Clone ID

Description

TIGR

Fold-change
vs. Vehicle

Control Down-regulated
AW415941

TC228784

Ssc.23329.1.S1_at

----------------------------

homologue to (Q8G137) Peptidase M23/M37 family

-7.03

BX666127

TC214846

Ssc.22627.1.S1_at

scag0007c.d.07

similar to Homo sapiens neuronal pentraxin II (BC035339)

-6.01

CN166439

TC220582

Ssc.3012.1.S1_at

-----------------------------

similar to UP|UPP1_MOUSE (P52624) Uridine phosphorylase 1 (UrdPase 1) (UPase 1) , partial (92%)

-4.57

CB285513

TC205551

Ssc.16460.1.S1_at

PPSUBLIB_05B01

homologue to UP|EGR1_HUMAN (P18146) Early growth response protein 1 (EGR-1)
(Krox-24 protein) (ZIF268) (Nerve growth factor-induced protein A) (NGFI-A)
(Transcription factor ETR103) (Zinc finger protein 225) (AT225), partial (20%)

-4.15

CF366280

TC199890

Ssc.17026.1.S1_at

-----------------------------

UP|Q69DL1 (Q69DL1) Complement C4 (Fragment), complete

-3.44

BQ603077

TC205573

Ssc.19629.2.S1_s_at

MI-P-NA-afp-b-10-1-UM

(Q6IP63) MGC78926 protein

-3.33

CO947935

TC217828

Ssc.30021.1.A1_at

-----------------------------

--------------

-2.68

CF365775

TC204812

Ssc.8564.1.A1_at

-----------------------------

homologue to UP|Q91YY0 (Q91YY0) Vldlr protein, partial (28%)

-2.67

BQ601267

TC225079

Ssc.13431.1.A1_at

MI-P-H3-afa-b-07-1-UM

--------------

-2.55

NM_214038

------------

Ssc.141.1.S1_at

-----------------------------

Sus scrofa prohormone convertase (PC13)

-2.14

AJ301332

TC221739

Ssc.10942.1.S1_at

09B02dT3

homologue to UP|Q5XIV3 (Q5XIV3) Enolase 3, beta, complete

-2.10

CK460825

TC221784

Ssc.17286.1.A1_at

-----------------------------

similar to Human B-cell translocation gene 2 (HSU72649)

-2.06

BX921013

TC235477

Ssc.25700.1.S1_at

scan0004d.d.22

similar to UP|Q8N5K8 (Q8N5K8) B-cell scaffold protein with ankyrin repeats 1, partial (8%)

-1.89

BI184308

------------

Ssc.11744.1.A1_at

UNL-P-FN-ck-g-09-0-UNL

similar to Bos taurus multiple coiled-coil GABABR1-binding protein (XM_589638)

-1.85

NM_214287

------------

Ssc.16342.1.A1_at

-----------------------------

Sus scrofa nexin-1 (PN-1)

-1.80

BX917032

------------

Ssc.25458.1.S1_at

scan0034d.b.15

similar to Homo sapiens testican-1 mRNA (AF231124)

-1.72

BQ602610

TC209620

Ssc.13529.1.A1_at

MI-P-NA-aeo-b-10-1-UM

similar to (Q8E1V6) Hypothetical protein SAG0245

-1.70

BQ600663

TC204479

Ssc.5696.1.S1_at

MI-P-E7-agz-h-04-1-UM

homologue to UP|PLE2_HUMAN (Q9NYT0) Pleckstrin 2, complete

-1.65

(Table 5.1 continued)
Accession No.
GenBank

Affymetrix Probe

Clone ID

Description

TIGR

Fold-change
vs. Vehicle

Control Down-regulated
BQ600843

TC211104

Ssc.1477.1.A1_at

MI-P-E7-ahs-f-10-1-UM

CO954537

------------

Ssc.29372.1.A1_at

-----------------------------

similar to (Q95UF3) Serine-threonine protein kinase

-1.65

similar to Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 3
-1.54
(PLCXD3) (NM_001005473)
CF180854

TC221412

Ssc.10931.1.S1_at

-----------------------------

UP|Q7M2W6 (Q7M2W6) Alpha-b crystallin, complete

-1.51

CK467066

TC220558

Ssc.17965.1.S1_at

-----------------------------

similar to UP|Q6DE63 (Q6DE63) MGC80058 protein, partial (91%)

-1.51

CN166587

TC227308

Ssc.24329.1.A1_at

-----------------------------

homologue to UP|Q8CIH5 (Q8CIH5) Phospholipase C, gamma 2, partial (10%)

-1.51

Control Up-regulated
BX676059

TC201683

Ssc.15893.1.S1_at

scag0009c.h.03

weakly similar to UP|GSM1_HUMAN (P57764) Gasdermin domain containing protein 1, partial (92%)

2.97

CN031558

------------

Ssc.28097.1.A1_at

-----------------------------

--------------

2.18

BI182553

------------

Ssc.11437.1.A1_at

UNL-P-FN-an-b-10-0-UNL

similar to Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L) (NM_145244)

1.94

CK461132

TC234893

Ssc.5333.1.S1_at

-----------------------------

homologue to UP|Q80TI6 (Q80TI6) MKIAA1170 protein (Fragment), partial (13%)

1.93

BI342348

TC226733

Ssc.6112.1.S1_at

-----------------------------

--------------

1.87

BI183043

TC237246

Ssc.11494.1.A1_at

UNL-P-FN-bt-d-11-0-UNL

similar to UP|O72510 (O72510) Polyprotein (Fragment), partial (10%)

1.56

CF180368

TC225432

Ssc.18601.1.A1_at

-----------------------------

--------------

1.50

Index Down-regulated
AW415941

TC228784

Ssc.23329.1.S1_at

-----------------------------

homologue to (Q8G137) Peptidase M23/M37 family

-4.29

BI404208

TC219862

Ssc.31160.1.A1_s_at

MI-P-CP1-nww-f-11-0-UI

homologue to UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit, partial (64%)

-3.08

CN158797

TC206965

Ssc.6219.1.A1_at

-----------------------------

(P24903) Cytochrome P450 2F1 (CYPIIF1) (EC 1.14.14.1 EC 1.14.14.1 EC 1.14.14.1)

-2.52

(Table 5.1 continued)
Accession No.
GenBank

Affymetrix Probe

Clone ID

Description

TIGR

Fold-change
vs. Vehicle

Index Down-regulated
BQ601267

TC225079

Ssc.13431.1.A1_at

MI-P-H3-afa-b-07-1-UM

--------------

-2.49

CN153818

TC223395

Ssc.27166.1.S1_at

-----------------------------

UP|Q6DLU9 (Q6DLU9) 6A3-5 protein, complete

-2.19

CF366280

TC199890

Ssc.17026.1.S1_at

-----------------------------

UP|Q69DL1 (Q69DL1) Complement C4 (Fragment), complete

-2.09

BQ602610

TC209620

Ssc.13529.1.A1_at

MI-P-NA-aeo-b-10-1-UM

similar to (Q8E1V6) Hypothetical protein SAG0245

-2.01

BI360888

TC199713

Ssc.4957.1.S1_at

-----------------------------

homologue to (Q6PEZ8) Hypothetical protein FLJ23447

-1.71

CF180652

TC202026

Ssc.5118.1.S1_at

-----------------------------

homologue to UP|A8B1_HUMAN (O43520) Potential phospholipid-transporting ATPase IC
-1.70
(Familial intrahepatic cholestasis type 1) (ATPase class I type 8B member 1) , partial (64%)
BI400383

------------

Ssc.10264.1.A1_at

MI-P-AY1-nqw-a-08-0-UI

similar to Human protein tyrosine phosphatase mRNA (M64572)

-1.65

BQ601792

TC209582

Ssc.14310.1.A1_at

MI-P-HO-afx-c-02-1-UM

homologue to UP|Q5SWM5 (Q5SWM5) Novel zinc finger protein, partial (6%)

-1.57

CK456522

TC211611

Ssc.24067.1.A1_at

-----------------------------

similar to (Q60KN8) Hypothetical protein CBG23978

-1.55

Index Up-regulated
BQ604090

------------

Ssc.30883.1.A1_at

MI-P-CP1-nza-o-21-0-UI

similar to Homo sapiens GREB1 protein (GREB1), transcript variant a (NM_014668)

1.62

NM_214337

------------

Ssc.13002.1.S1_at

-----------------------------

Sus scrofa 17-kDa PKC-potentiated inhibitory protein of PP1 (PPP1R14A)

1.55

CO956777

TC202434

Ssc.6478.1.A1_at

-----------------------------

similar to UP|CCD3_MOUSE (Q9D6Y1) Coiled-coil domain containing protein 3 precursor, partial (38%)

1.52

BX914448

TC206366

Ssc.26203.1.S1_at

scan0001f.d.23

similar to UP|KF12_HUMAN (Q96FN5) Kinesin-like protein KIF12 (Fragment), partial (96%)

1.50

CF792374

TC222623

Ssc.22063.1.S1_at

-----------------------------

homologue to UP|EXC7_RAT (O54922) Exocyst complex component 7 (Exocyst complex component
Exo70) (rExo70), partial (63%)

1.50

Ssc.22627.1.S1_at

scag0007c.d.07

similar to Homo sapiens neuronal pentraxin II (BC035339)

-3.63

Meishan Down-regulated
BX666127

TC214846

(Table 5.1 continued)
Accession No.
GenBank

Affymetrix Probe

Clone ID

Description

TIGR

Fold-change
vs. Vehicle

Meishan Down-regulated
AW415941

TC228784

Ssc.23329.1.S1_at

-----------------------------

homologue to (Q8G137) Peptidase M23/M37 family

-3.20

BI404208

TC219862

Ssc.31160.1.A1_s_at

MI-P-CP1-nww-f-11-0-UI

homologue to UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit, partial (64%)

-2.73

BQ603633

TC224265

Ssc.4552.1.S1_at

MI-P-CP0-nvg-h-03-0-UI

homologue to GB|BAA03946.1|391736|HUMVLDLRB very low density lipoprotein receptor
{Homo sapiens;} , partial (42%)

-2.10

BQ601267

TC225079

Ssc.13431.1.A1_at

MI-P-H3-afa-b-07-1-UM

--------------

-2.03

CF365775

TC204812

Ssc.8564.1.A1_at

-----------------------------

homologue to UP|Q91YY0 (Q91YY0) Vldlr protein, partial (28%)

-2.02

CK462890

TC219862

Ssc.14999.1.A1_at

-----------------------------

homologue to UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit, partial (64%)

-1.67

CN166587

TC227308

Ssc.24329.1.A1_at

-----------------------------

homologue to UP|Q8CIH5 (Q8CIH5) Phospholipase C, gamma 2, partial (10%)

-1.64

Meishan Up-regulated
CN031558

------------

Ssc.28097.1.A1_at

-----------------------------

--------------

2.34

CO956126

TC204810

Ssc.9688.1.S1_at

-----------------------------

(O43005) SPBC2G2.06c protein (Apl1 protein)

2.27

AW480026

TC233646

Ssc.30625.1.S1_at

-----------------------------

similar to (Q60D66) Hypothetical protein OSJNBa0073C10.14

2.13

BI182553

------------

Ssc.11437.1.A1_at

UNL-P-FN-an-b-10-0-UNL

similar to Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L) (NM_145244)

2.13

BI119477

TC203393

Ssc.7093.3.S1_at

-----------------------------

similar to UP|Q9NF31 (Q9NF31) EG:BACN25G24.3 protein (Fbgn0004860;ph-d protein)

2.05

CO987486

TC226214

Ssc.31164.1.S1_at

-----------------------------

similar to (Q671A1) Ellis van Creveld protein-like

1.87

CK457106

TC227683

Ssc.24173.1.S1_at

-----------------------------

similar to Homo sapiens transmembrane protein 46 (TMEM46) (NM_001007538)

1.81

BQ597811

------------

Ssc.10731.1.A1_at

MI-P-A2-afg-a-12-1-UM

similar to Homo sapiens pregnancy-associated plasma protein A, pappalysin 1 (BC078657)

1.80

(Table 5.1 continued)
Accession No.
GenBank

Affymetrix Probe

Clone ID

Description

TIGR

Fold-change
vs. Vehicle

Meishan Up-regulated
AJ656944

TC205995

Ssc.14352.1.S1_at

C0005194_A20

similar to (Q7YX45) Hypothetical protein F07B10.4

1.78

BQ602964

------------

Ssc.13635.1.A1_at

MI-P-NA-aes-e-12-1-UM

--------------

1.78

CF789721

TC237052

Ssc.22266.1.A1_at

-----------------------------

homologue to (Q661N6) Basic membrane protein A1 precursor (Immunodominant antigen P39)

1.71

BQ603378

TC233830

Ssc.2834.1.A1_at

MI-P-NA-afs-g-11-1-UM

UP|GIDB_MYCGE (P47620) Methyltransferase gidB (Glucose inhibited division protein B) , partial (5%)

1.69

CF368424

TC205594

Ssc.1609.1.A1_at

-----------------------------

similar to (Q74LP0) Hypothetical protein

1.61

CK461456

TC222351

Ssc.19651.1.S1_at

-----------------------------

similar to UP|Q655C0 (Q655C0) Seed specific protein, 5'-partial-like protein, partial (6%)

1.60

CN069958

TC222178

Ssc.6218.1.S1_at

-----------------------------

homologue to UP|Q62CX7 (Q62CX7) Oxidoreductase, short-chain dehydrogenase/reductase family,
partial (5%)

1.60

NM_001001865

------------

Ssc.20177.1.S1_at

-----------------------------

Sus scrofa transcription factor PU.1

1.59

BF198220

TC221910

Ssc.4029.1.S1_a_at

-----------------------------

homologue to UP|SHB2_HUMAN (Q9NR46) SH3 domain GRB2-like protein B2 (Endophilin B2)
(PP578), partial (91%)

1.58

CF792574

TC218158

Ssc.22390.1.A1_at

-----------------------------

(Q6ZU13) Hypothetical protein FLJ44064

1.58

CN163273

TC201594

Ssc.21436.1.S1_at

-----------------------------

homologue to UP|Q9P1S7 (Q9P1S7) HDCMA18P, complete

1.56

BF708730

TC212964

Ssc.8919.1.S1_at

MI-P-AY0-nai-b-05-0-UI

--------------

1.55

CN166215

------------

Ssc.27062.1.A1_at

-----------------------------

--------------

1.55

CO987060

TC223977

Ssc.25067.1.S1_at

-----------------------------

similar to UP|DAPB_NITEU (Q82WP9) Dihydrodipicolinate reductase (DHPR) , partial (5%)

1.54

BI400498

TC216136

Ssc.10007.1.A1_at

MI-P-AY1-nrw-g-01-0-UI

similar to (Q8HG39) NADH dehydrogenase subunit 5

1.52

CA778753

TC219247

Ssc.23486.1.S1_at

pSPORT1

homologue to UP|Q9DCM0 (Q9DCM0) Mus musculus adult male kidney cDNA,
RIKEN full-length enriched library, clone:0610025L15 product:PROTEIN EXPRESSED IN THYROID
homolog (ETHE1 protein) (HSCO protein), complete

1.51

CO950299

TC225152

Ssc.66.1.S3_at

-----------------------------

(Q7RMM2) Hypothetical protein

1.51
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